当前蛋白身份:P19491 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1FTJ CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH GLUTAMATE AT 1.9 RESOLUTION 提交 2000-09-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J))
未记录 ZN ZINC ION × 1 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.1 M Cacodylate 15% PEG 8000 0.2 M Zinc Acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 4K
分辨率 1.90 Å R-free 0.266
1FTJ CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH GLUTAMATE AT 1.9 RESOLUTION 提交 2000-09-12 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J))
未记录 ZN ZINC ION × 2 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.1 M Cacodylate 15% PEG 8000 0.2 M Zinc Acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 4K
分辨率 1.90 Å R-free 0.266
1FTJ CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH GLUTAMATE AT 1.9 RESOLUTION 提交 2000-09-12 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J))
未记录 ZN ZINC ION × 2 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.1 M Cacodylate 15% PEG 8000 0.2 M Zinc Acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 4K
分辨率 1.90 Å R-free 0.266
1FTJ CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH GLUTAMATE AT 1.9 RESOLUTION 提交 2000-09-12 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J))
未记录 ZN ZINC ION × 5 GLU GLUTAMIC ACID × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.1 M Cacodylate 15% PEG 8000 0.2 M Zinc Acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 4K
分辨率 1.90 Å R-free 0.266
1FTJ CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH GLUTAMATE AT 1.9 RESOLUTION 提交 2000-09-12 Assembly 5 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J))
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J))
未记录 ZN ZINC ION × 3 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.1 M Cacodylate 15% PEG 8000 0.2 M Zinc Acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 4K
分辨率 1.90 Å R-free 0.266
1FTK CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2I) IN COMPLEX WITH KAINATE AT 1.6 A RESOLUTION 提交 2000-09-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 404–528(125 aa) 片段:LIGAND BINDING CORE, S1S2I
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE, S1S2I
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15% PEG 8000 50 mM potassium phosphate , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.60 Å R-free 0.261
1FTL CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH THE ANTAGONIST DNQX AT 1.8 A RESOLUTION 提交 2000-09-12 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 DNQ 6,7-DINITROQUINOXALINE-2,3-DIONE × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;19% PEG 4000 0.3 M ammonium sulfate 0.1 M sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.272
1FTM CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH AMPA AT 1.7 RESOLUTION 提交 2000-09-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 1 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15% PEG 8000 0.2 M Zinc Acetate 0.1 M Cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.247
1FTM CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH AMPA AT 1.7 RESOLUTION 提交 2000-09-12 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 2 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15% PEG 8000 0.2 M Zinc Acetate 0.1 M Cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.247
1FTM CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH AMPA AT 1.7 RESOLUTION 提交 2000-09-12 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 413–527(115 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 2 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15% PEG 8000 0.2 M Zinc Acetate 0.1 M Cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.247
1FTM CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH AMPA AT 1.7 RESOLUTION 提交 2000-09-12 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15% PEG 8000 0.2 M Zinc Acetate 0.1 M Cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.247
1FTM CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH AMPA AT 1.7 RESOLUTION 提交 2000-09-12 Assembly 5 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:GLUR2-FLOP LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15% PEG 8000 0.2 M Zinc Acetate 0.1 M Cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.247
1FTO CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN THE APO STATE AT 2.0 A RESOLUTION 提交 2000-09-12 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;22% PEG 8000 0.3 M ammonium sulfate 0.1 M sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.287
1FTO CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN THE APO STATE AT 2.0 A RESOLUTION 提交 2000-09-12 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;22% PEG 8000 0.3 M ammonium sulfate 0.1 M sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.287
1FW0 CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH KAINATE AT 2.0 A RESOLUTION 提交 2000-09-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;274 K;10% PEG 1450, 0.1 M sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 274K
分辨率 1.90 Å R-free 0.308
1GR2 STRUCTURE OF A GLUTAMATE RECEPTOR LIGAND BINDING CORE (GLUR2) COMPLEXED WITH KAINATE 提交 1998-09-17 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 404–528(125 aa) 片段:LIGAND BINDING DOMAIN
链 A 652–796(145 aa) 片段:LIGAND BINDING DOMAIN
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 5;50 MM KIPI, PH 5.0, 14% PEG 8K
分辨率 1.90 Å R-free 0.273
1LB8 Crystal structure of the Non-desensitizing GluR2 ligand binding core mutant (S1S2J-L483Y) in complex with AMPA at 2.3 resolution 提交 2002-04-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand-binding core (flop)
链 A 653–796(144 aa) 片段:ligand-binding core (flop)
突变:L483Y 突变:L483Y AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;PEG 8000, ammonium sulfate, sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
分辨率 2.30 Å R-free 0.267
1LB8 Crystal structure of the Non-desensitizing GluR2 ligand binding core mutant (S1S2J-L483Y) in complex with AMPA at 2.3 resolution 提交 2002-04-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:ligand-binding core (flop)
链 B 653–796(144 aa) 片段:ligand-binding core (flop)
突变:L483Y 突变:L483Y AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;PEG 8000, ammonium sulfate, sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
分辨率 2.30 Å R-free 0.267
1LB9 Crystal structure of the Non-desensitizing GluR2 ligand binding core mutant (S1S2J-L483Y) in complex with antagonist DNQX at 2.3 A resolution 提交 2002-04-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (flop)
链 A 653–796(144 aa) 片段:ligand binding core (flop)
突变:L483Y 突变:L483Y DNQ 6,7-DINITROQUINOXALINE-2,3-DIONE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;PEG 4000, ammonium sulfate, sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
分辨率 2.30 Å R-free 0.268
1LB9 Crystal structure of the Non-desensitizing GluR2 ligand binding core mutant (S1S2J-L483Y) in complex with antagonist DNQX at 2.3 A resolution 提交 2002-04-02 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:ligand binding core (flop)
链 B 653–796(144 aa) 片段:ligand binding core (flop)
突变:L483Y 突变:L483Y DNQ 6,7-DINITROQUINOXALINE-2,3-DIONE × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;PEG 4000, ammonium sulfate, sodium acetate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
分辨率 2.30 Å R-free 0.268
1LBB Crystal structure of the GluR2 ligand binding domain mutant (S1S2J-N754D) in complex with kainate at 2.1 A resolution 提交 2002-04-02 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (flop)
链 A 653–796(144 aa) 片段:ligand binding core (flop)
突变:N754D 突变:N754D KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PEG 1000, Li2SO4, phosphate-citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
分辨率 2.10 Å R-free 0.260
1M5B X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH 2-Me-Tet-AMPA AT 1.85 A RESOLUTION. 提交 2002-07-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:flop ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:flop ligand binding core (S1S2J)
链 C 413–527(115 aa) 片段:flop ligand binding core (S1S2J)
链 C 653–796(144 aa) 片段:flop ligand binding core (S1S2J)
未记录 ZN ZINC ION × 3 BN1 (S)-2-AMINO-3-[3-HYDROXY-5-(2-METHYL-2H-TETRAZOL-5-YL)ISOXAZOL-4-YL]PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.85 Å R-free 0.234
1M5B X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH 2-Me-Tet-AMPA AT 1.85 A RESOLUTION. 提交 2002-07-09 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:flop ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:flop ligand binding core (S1S2J)
未记录 ZN ZINC ION × 4 BN1 (S)-2-AMINO-3-[3-HYDROXY-5-(2-METHYL-2H-TETRAZOL-5-YL)ISOXAZOL-4-YL]PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.85 Å R-free 0.234
1M5B X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH 2-Me-Tet-AMPA AT 1.85 A RESOLUTION. 提交 2002-07-09 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:flop ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:flop ligand binding core (S1S2J)
链 B 413–527(115 aa) 片段:flop ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:flop ligand binding core (S1S2J)
链 C 413–527(115 aa) 片段:flop ligand binding core (S1S2J)
链 C 653–796(144 aa) 片段:flop ligand binding core (S1S2J)
未记录 ZN ZINC ION × 5 BN1 (S)-2-AMINO-3-[3-HYDROXY-5-(2-METHYL-2H-TETRAZOL-5-YL)ISOXAZOL-4-YL]PROPIONIC ACID × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.85 Å R-free 0.234
1M5C X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH Br-HIBO AT 1.65 A RESOLUTION 提交 2002-07-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:flop ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:flop ligand binding core (S1S2J)
未记录 BRH (S)-2-AMINO-3-(4-BROMO-3-HYDROXY-ISOXAZOL-5-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;PEG 1450, Li2SO4, phosphate-citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.65 Å R-free 0.221
1M5D X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J-Y702F) IN COMPLEX WITH Br-HIBO AT 1.73 A RESOLUTION 提交 2002-07-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 A 653–796(144 aa) 片段:flop ligand binding core (S1S2J-Y702F)
突变:Y190F 突变:Y190F SO4 SULFATE ION × 4 BRH (S)-2-AMINO-3-(4-BROMO-3-HYDROXY-ISOXAZOL-5-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;PEG 3350, Li2SO4, phosphate-citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.73 Å R-free 0.215
1M5E X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH ACPA AT 1.46 A RESOLUTION 提交 2002-07-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 C 413–527(115 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 C 653–796(144 aa) 片段:GluR2-flop ligand binding core (S1S2J)
未记录 ZN ZINC ION × 4 AM1 (S)-2-AMINO-3-(3-CARBOXY-5-METHYLISOXAZOL-4-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.46 Å R-free 0.216
1M5E X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH ACPA AT 1.46 A RESOLUTION 提交 2002-07-09 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:GluR2-flop ligand binding core (S1S2J)
未记录 ZN ZINC ION × 8 AM1 (S)-2-AMINO-3-(3-CARBOXY-5-METHYLISOXAZOL-4-YL)PROPIONIC ACID × 2 ACT ACETATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.46 Å R-free 0.216
1M5E X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH ACPA AT 1.46 A RESOLUTION 提交 2002-07-09 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 B 413–527(115 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 C 413–527(115 aa) 片段:GluR2-flop ligand binding core (S1S2J)
链 C 653–796(144 aa) 片段:GluR2-flop ligand binding core (S1S2J)
未记录 ZN ZINC ION × 8 AM1 (S)-2-AMINO-3-(3-CARBOXY-5-METHYLISOXAZOL-4-YL)PROPIONIC ACID × 3 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.46 Å R-free 0.216
1M5F X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J-Y702F) IN COMPLEX WITH ACPA AT 1.95 A RESOLUTION 提交 2002-07-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 A 653–796(144 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 C 413–527(115 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 C 653–796(144 aa) 片段:flop ligand binding core (S1S2J-Y702F)
突变:Y190F 突变:Y190F 突变:Y190F 突变:Y190F ZN ZINC ION × 2 AM1 (S)-2-AMINO-3-(3-CARBOXY-5-METHYLISOXAZOL-4-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.95 Å R-free 0.230
1M5F X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J-Y702F) IN COMPLEX WITH ACPA AT 1.95 A RESOLUTION 提交 2002-07-09 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 B 653–796(144 aa) 片段:flop ligand binding core (S1S2J-Y702F)
突变:Y190F 突变:Y190F ZN ZINC ION × 8 AM1 (S)-2-AMINO-3-(3-CARBOXY-5-METHYLISOXAZOL-4-YL)PROPIONIC ACID × 2 ACT ACETATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.95 Å R-free 0.230
1M5F X-RAY STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J-Y702F) IN COMPLEX WITH ACPA AT 1.95 A RESOLUTION 提交 2002-07-09 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 A 653–796(144 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 B 413–527(115 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 B 653–796(144 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 C 413–527(115 aa) 片段:flop ligand binding core (S1S2J-Y702F)
链 C 653–796(144 aa) 片段:flop ligand binding core (S1S2J-Y702F)
突变:Y190F 突变:Y190F 突变:Y190F 突变:Y190F 突变:Y190F 突变:Y190F ZN ZINC ION × 6 AM1 (S)-2-AMINO-3-(3-CARBOXY-5-METHYLISOXAZOL-4-YL)PROPIONIC ACID × 3 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 8000, Zn(OAc)2, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.95 Å R-free 0.230
1MM6 crystal structure of the GluR2 ligand binding core (S1S2J) in complex with quisqualate in a non zinc crystal form at 2.15 angstroms resolution 提交 2002-09-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 SO4 SULFATE ION × 3 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;PEG 8K, ammonium sulfate, sodium citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.15 Å R-free 0.237
1MM7 Crystal Structure of the GluR2 Ligand Binding Core (S1S2J) in Complex with Quisqualate in a Zinc Crystal Form at 1.65 Angstroms Resolution 提交 2002-09-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;PEG 8K, zinc acetate, sodium acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.65 Å R-free 0.237
1MM7 Crystal Structure of the GluR2 Ligand Binding Core (S1S2J) in Complex with Quisqualate in a Zinc Crystal Form at 1.65 Angstroms Resolution 提交 2002-09-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;PEG 8K, zinc acetate, sodium acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.65 Å R-free 0.237
1MQD X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-Des-Me-AMPA at 1.46 A resolution. Crystallization in the presence of lithium sulfate. 提交 2002-09-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 A 653–794(142 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 SO4 SULFATE ION × 2 SHI (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.2;279 K;20% PEG 8000, 0.1M lithium sulfate, 0.1M cacodylate, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.46 Å R-free 0.192
1MQD X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-Des-Me-AMPA at 1.46 A resolution. Crystallization in the presence of lithium sulfate. 提交 2002-09-16 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 B 653–794(142 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 SO4 SULFATE ION × 2 SHI (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.2;279 K;20% PEG 8000, 0.1M lithium sulfate, 0.1M cacodylate, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.46 Å R-free 0.192
1MQD X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-Des-Me-AMPA at 1.46 A resolution. Crystallization in the presence of lithium sulfate. 提交 2002-09-16 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 C 653–794(142 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 SHI (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.2;279 K;20% PEG 8000, 0.1M lithium sulfate, 0.1M cacodylate, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.46 Å R-free 0.192
1MQD X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-Des-Me-AMPA at 1.46 A resolution. Crystallization in the presence of lithium sulfate. 提交 2002-09-16 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 D 653–794(142 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 SO4 SULFATE ION × 2 SHI (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.2;279 K;20% PEG 8000, 0.1M lithium sulfate, 0.1M cacodylate, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.46 Å R-free 0.192
1MQG Crystal Structure of the GluR2 Ligand Binding Core (S1S2J) in Complex with Iodo-Willardiine at 2.15 Angstroms Resolution 提交 2002-09-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 B 413–527(115 aa) 片段:ligand binding core (S1S2J)
未记录 SO4 SULFATE ION × 2 IWD 2-AMINO-3-(5-IODO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.2;277 K;PEG 1000, Phosphate-citrate buffer, Li sulfate, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.15 Å R-free 0.233
1MQH Crystal Structure of the GluR2 Ligand Binding Core (S1S2J) in Complex with Bromo-Willardiine at 1.8 Angstroms Resolution 提交 2002-09-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:ligand binding core (S1S2J)
未记录 BWD 2-AMINO-3-(5-BROMO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;PEG 8K, ammonium sulfate, Na Acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.231
1MQI Crystal Structure of the GluR2 Ligand Binding Core (S1S2J) in Complex with Fluoro-Willardiine at 1.35 Angstroms Resolution 提交 2002-09-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
未记录 FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;PEG 8K, NaCl, Na Citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.35 Å R-free 0.218
1MQJ Crystal structure of the GluR2 ligand binding core (S1S2J) in complex with willardiine at 1.65 angstroms resolution 提交 2002-09-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
未记录 ZN ZINC ION × 2 HWD 2-AMINO-3-(2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;PEG 5K MME, Na Citrate, zinc acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.65 Å R-free 0.229
1MS7 X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-Des-Me-AMPA at 1.97 A resolution, Crystallization in the presence of zinc acetate 提交 2002-09-19 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 A 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 C 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 C 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 ZN ZINC ION × 2 SHI (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;17% PEG 8000, 0.05M zinc acetate, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.97 Å R-free 0.213
1MS7 X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-Des-Me-AMPA at 1.97 A resolution, Crystallization in the presence of zinc acetate 提交 2002-09-19 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 B 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 ZN ZINC ION × 8 SHI (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;17% PEG 8000, 0.05M zinc acetate, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.97 Å R-free 0.213
1MS7 X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-Des-Me-AMPA at 1.97 A resolution, Crystallization in the presence of zinc acetate 提交 2002-09-19 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 A 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 B 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 B 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 C 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 C 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 ZN ZINC ION × 6 SHI (S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;17% PEG 8000, 0.05M zinc acetate, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.97 Å R-free 0.213
1MXU CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) in complex with bromo-willardiine (Control for the crystal titration experiments) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 BWD 2-AMINO-3-(5-BROMO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8K, ammonium sulfate, zinc acetate, BrW and sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.234
1MXU CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) in complex with bromo-willardiine (Control for the crystal titration experiments) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 BWD 2-AMINO-3-(5-BROMO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8K, ammonium sulfate, zinc acetate, BrW and sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.234
1MXU CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) in complex with bromo-willardiine (Control for the crystal titration experiments) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 BWD 2-AMINO-3-(5-BROMO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8K, ammonium sulfate, zinc acetate, BrW and sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.234
1MXV crystal titration experiments (AMPA co-crystals soaked in 10 mM BrW) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.95 Å R-free 0.248
1MXV crystal titration experiments (AMPA co-crystals soaked in 10 mM BrW) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.95 Å R-free 0.248
1MXV crystal titration experiments (AMPA co-crystals soaked in 10 mM BrW) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.95 Å R-free 0.248
1MXW crystal titration experiments (AMPA co-crystals soaked in 1 mM BrW) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.252
1MXW crystal titration experiments (AMPA co-crystals soaked in 1 mM BrW) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.252
1MXW crystal titration experiments (AMPA co-crystals soaked in 1 mM BrW) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.252
1MXX crystal titration experiments (AMPA co-crystals soaked in 100 uM BrW) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.250
1MXX crystal titration experiments (AMPA co-crystals soaked in 100 uM BrW) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.250
1MXX crystal titration experiments (AMPA co-crystals soaked in 100 uM BrW) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.250
1MXY crystal titration experiments (AMPA co-crystals soaked in 10 uM BrW) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.95 Å R-free 0.259
1MXY crystal titration experiments (AMPA co-crystals soaked in 10 uM BrW) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.95 Å R-free 0.259
1MXY crystal titration experiments (AMPA co-crystals soaked in 10 uM BrW) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.95 Å R-free 0.259
1MXZ crystal titration experiments (AMPA co-crystals soaked in 1 uM BrW) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.256
1MXZ crystal titration experiments (AMPA co-crystals soaked in 1 uM BrW) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.256
1MXZ crystal titration experiments (AMPA co-crystals soaked in 1 uM BrW) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.256
1MY0 crystal titration experiments (AMPA co-crystals soaked in 100 nM BrW) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.249
1MY0 crystal titration experiments (AMPA co-crystals soaked in 100 nM BrW) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.249
1MY0 crystal titration experiments (AMPA co-crystals soaked in 100 nM BrW) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.249
1MY1 crystal titration experiments (AMPA co-crystals soaked in 10 nM BrW) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.248
1MY1 crystal titration experiments (AMPA co-crystals soaked in 10 nM BrW) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.248
1MY1 crystal titration experiments (AMPA co-crystals soaked in 10 nM BrW) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.248
1MY2 crystal titration experiment (AMPA complex control) 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.244
1MY2 crystal titration experiment (AMPA complex control) 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.244
1MY2 crystal titration experiment (AMPA complex control) 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, zinc acetate, sodium cacodylate, pH 6.5 and AMPA, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.244
1MY3 crystal structure of glutamate receptor ligand-binding core in complex with bromo-willardiine in the Zn crystal form 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 BWD 2-AMINO-3-(5-BROMO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, ammonium sulfate, zinc acetate and sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.75 Å R-free 0.255
1MY3 crystal structure of glutamate receptor ligand-binding core in complex with bromo-willardiine in the Zn crystal form 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 BWD 2-AMINO-3-(5-BROMO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, ammonium sulfate, zinc acetate and sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.75 Å R-free 0.255
1MY4 crystal structure of glutamate receptor ligand-binding core in complex with iodo-willardiine in the Zn crystal form 提交 2002-10-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 IWD 2-AMINO-3-(5-IODO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PEG4K, ammonium sulfate, zinc acetate and Tris-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.262
1MY4 crystal structure of glutamate receptor ligand-binding core in complex with iodo-willardiine in the Zn crystal form 提交 2002-10-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 IWD 2-AMINO-3-(5-IODO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PEG4K, ammonium sulfate, zinc acetate and Tris-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.262
1MY4 crystal structure of glutamate receptor ligand-binding core in complex with iodo-willardiine in the Zn crystal form 提交 2002-10-03 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–796(144 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 5 IWD 2-AMINO-3-(5-IODO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PEG4K, ammonium sulfate, zinc acetate and Tris-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.262
1N0T X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with the antagonist (S)-ATPO at 2.1 A resolution. 提交 2002-10-15 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J).
链 A 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J).
链 C 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J).
链 C 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J).
未记录 AT1 (S)-2-AMINO-3-(5-TERT-BUTYL-3-(PHOSPHONOMETHOXY)-4-ISOXAZOLYL)PROPIONIC ACID × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.2;279 K;PEG 3350, AMMONIUM SULFATE, SODIUM ACETATE pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.10 Å R-free 0.245
1N0T X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with the antagonist (S)-ATPO at 2.1 A resolution. 提交 2002-10-15 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J).
链 B 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J).
链 D 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J).
链 D 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J).
未记录 AT1 (S)-2-AMINO-3-(5-TERT-BUTYL-3-(PHOSPHONOMETHOXY)-4-ISOXAZOLYL)PROPIONIC ACID × 2 SO4 SULFATE ION × 2 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.2;279 K;PEG 3350, AMMONIUM SULFATE, SODIUM ACETATE pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.10 Å R-free 0.245
1NNK X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-ATPA at 1.85 A resolution. Crystallization with zinc ions. 提交 2003-01-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 A 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 ZN ZINC ION × 4 CL CHLORIDE ION × 2 CE2 3-(5-TERT-BUTYL-3-OXIDOISOXAZOL-4-YL)-L-ALANINATE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;zinc acetate, cacodylate, PEG8000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.85 Å R-free 0.245
1NNP X-ray structure of the GluR2 ligand-binding core (S1S2J) in complex with (S)-ATPA at 1.9 A resolution. Crystallization without zinc ions. 提交 2003-01-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
链 B 653–796(144 aa) 片段:GluR2-flop ligand-binding core (S1S2J)
未记录 SO4 SULFATE ION × 2 CE2 3-(5-TERT-BUTYL-3-OXIDOISOXAZOL-4-YL)-L-ALANINATE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.6;279 K;ammonium sulfate, PEG8000, sodium acetate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.90 Å R-free 0.216
1P1N GluR2 Ligand Binding Core (S1S2J) Mutant L650T in Complex with Kainate 提交 2003-04-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:L138T 突变:L138T KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;PEG 4000, ammonium sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.60 Å R-free 0.252
1P1O Crystal structure of the GluR2 ligand-binding core (S1S2J) mutant L650T in complex with quisqualate 提交 2003-04-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:L138T 突变:L138T SO4 SULFATE ION × 4 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;PEG4000, ammonium sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.60 Å R-free 0.235
1P1Q Crystal structure of the GluR2 ligand binding core (S1S2J) L650T mutant in complex with AMPA 提交 2003-04-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:ligand binding core (S1S2J)
链 C 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 C 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:L138T 突变:L138T 突变:L138T 突变:L138T ZN ZINC ION × 3 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, cacodylate, zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.270
1P1Q Crystal structure of the GluR2 ligand binding core (S1S2J) L650T mutant in complex with AMPA 提交 2003-04-13 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:L138T 突变:L138T ZN ZINC ION × 4 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;PEG8000, cacodylate, zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.270
1P1U Crystal structure of the GluR2 ligand-binding core (S1S2J) L650T mutant in complex with AMPA (ammonium sulfate crystal form) 提交 2003-04-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:ligand binding core (S1S2J)
链 B 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:L138T 突变:L138T 突变:L138T 突变:L138T SO4 SULFATE ION × 1 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;PEG4000, ammonium sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.271
1P1W Crystal structure of the GluR2 ligand-binding core (S1S2J) with the L483Y and L650T mutations and in complex with AMPA 提交 2003-04-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:ligand binding core (S1S2J)
链 B 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:L94Y,L138T 突变:L94Y,L138T 突变:L94Y,L138T 突变:L94Y,L138T SO4 SULFATE ION × 2 AMQ (S)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;PEG4000, ammonium sulfate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.264
1SYH X-RAY STRUCTURE OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-CPW399 AT 1.85 A RESOLUTION. 提交 2004-04-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–796(384 aa) 片段:GLUR2-FLOP LIGAND-BINDING CORE (S1S2J)
未记录 CPW (S)-2-AMINO-3-(1,3,5,7-PENTAHYDRO-2,4-DIOXO-CYCLOPENTA[E]PYRIMIDIN-1-YL) PROIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;280 K;PEG8000, cacodylate, (NH4)2SO4 , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 1.80 Å R-free 0.199
1SYI X-RAY STRUCTURE OF THE Y702F MUTANT OF THE GLUR2 LIGAND-BINDING CORE (S1S2J) IN COMPLEX WITH (S)-CPW399 AT 2.1 A RESOLUTION. 提交 2004-04-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–796(384 aa) 片段:GLUR2-FLOP LIGAND-BINDING CORE (S1S2J)
链 B 413–796(384 aa) 片段:GLUR2-FLOP LIGAND-BINDING CORE (S1S2J)
突变:Y702F 突变:Y702F CPW (S)-2-AMINO-3-(1,3,5,7-PENTAHYDRO-2,4-DIOXO-CYCLOPENTA[E]PYRIMIDIN-1-YL) PROIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;280 K;PEG8000, CACODYLATE, (NH4)2SO4, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.10 Å R-free 0.254
1WVJ Exploring the GluR2 ligand-binding core in complex with the bicyclic AMPA analogue (S)-4-AHCP 提交 2004-12-15 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
未记录 SO4 SULFATE ION × 4 IBC 3-(3-HYDROXY-7,8-DIHYDRO-6H-CYCLOHEPTA[D]ISOXAZOL-4-YL)-L-ALANINE × 2 GOL GLYCEROL × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;PEG 3350, phosphate-citrate buffer, lithium sulfate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.75 Å R-free 0.214
1XHY X-ray structure of the Y702F mutant of the GluR2 ligand-binding core (S1S2J) in complex with kainate at 1.85 A resolution 提交 2004-09-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2 flop ligand-binding core (S1S2J), UNP residues 413-527 and 653-796
链 A 653–796(144 aa) 片段:GluR2 flop ligand-binding core (S1S2J), UNP residues 413-527 and 653-796
突变:Y702F 突变:Y702F SO4 SULFATE ION × 10 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;280 K;PEG1000, Li2SO4, cacodylate , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 1.85 Å R-free 0.207
2AIX X-ray structure of the GLUR2 ligand-binding core (S1S2J) in complex with (s)-thio-atpa at 2.2 a resolution. 提交 2005-08-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GLUR2-FLOP LIGAND-BINDING CORE (S1S2J).
链 A 653–796(144 aa) 片段:GLUR2-FLOP LIGAND-BINDING CORE (S1S2J).
未记录 U1K (S)-2-AMINO-3-(3-HYDROXY-5-TERT-BUTYLISOTHIAZOL-4-YL) PROPRIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;279 K;SODIUM CHLORIDE, CACODYLATE, PEG 8000, pH 6.50, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.17 Å R-free 0.230
2AL4 CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH quisqualate and CX614. 提交 2005-08-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:ligand binding core (S1S2J)
链 B 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:ligand binding core (S1S2J)
链 F 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 F 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. ZN ZINC ION × 5 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 3 CX6 2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;10-14% PEG8000, 0.1-0.15 M Zinc acetate, 0.1 M sodium acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.223
2AL4 CRYSTAL STRUCTURE OF THE GLUR2 LIGAND BINDING CORE (S1S2J) IN COMPLEX WITH quisqualate and CX614. 提交 2005-08-04 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 C 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 C 653–796(144 aa) 片段:ligand binding core (S1S2J)
链 D 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 D 653–796(144 aa) 片段:ligand binding core (S1S2J)
链 E 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 E 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. ZN ZINC ION × 5 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 3 CX6 2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;10-14% PEG8000, 0.1-0.15 M Zinc acetate, 0.1 M sodium acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.223
2AL5 Crystal structure of the GluR2 ligand binding core (S1S2J) in complex with fluoro-willardiine and aniracetam 提交 2005-08-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 A 653–796(144 aa) 片段:ligand binding core (S1S2J)
链 B 413–527(115 aa) 片段:ligand binding core (S1S2J)
链 B 653–796(144 aa) 片段:ligand binding core (S1S2J)
突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. 突变:The native GluR2 is a membrane protein. Transmembrane regions were genetically removed and replaced with a Gly-Thr linker. FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 4MP 1-(4-METHOXYBENZOYL)-2-PYRROLIDINONE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;12-14% PEG 8000, 0.25-0.35 M ammonium sulfate and 0.1 M sodium citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.65 Å R-free 0.220
2ANJ Crystal Structure of the Glur2 Ligand Binding Core (S1S2J-Y450W) Mutant in Complex With the Partial Agonist Kainic Acid at 2.1 A Resolution 提交 2005-08-11 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand Binding Core
链 A 653–796(144 aa) 片段:Ligand Binding Core
突变:Y61W 突变:Y61W KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;279 K;PEG 8000, Cacodylate, Lithium Sulphate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K, pH 6.50
分辨率 2.10 Å R-free 0.248
2CMO The structure of a mixed glur2 ligand-binding core dimer in complex with (s)-glutamate and the antagonist (s)-ns1209 提交 2006-05-11 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:RESIDUES 413-527,653-796
链 A 653–796(144 aa) 片段:RESIDUES 413-527,653-796
链 B 413–527(115 aa) 片段:RESIDUES 413-527,653-796
链 B 653–796(144 aa) 片段:RESIDUES 413-527,653-796
未记录 SO4 SULFATE ION × 4 M1L 2-({[(3E)-5-{4-[(DIMETHYLAMINO)(DIHYDROXY)-LAMBDA~4~-SULFANYL]PHENYL}-8-METHYL-2-OXO-6,7,8,9-TETRAHYDRO-1H-PYRROLO[3,2-H]ISOQUINOLIN-3(2H)-YLIDENE]AMINO}OXY)-4-HYDROXYBUTANOIC ACID × 1 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;pH 6.50
分辨率 2.65 Å R-free 0.281
2GFE Crystal structure of the GluR2 A476E S673D Ligand Binding Core Mutant at 1.54 Angstroms Resolution 提交 2006-03-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–795(143 aa)
链 C 413–527(115 aa)
链 C 653–795(143 aa)
突变:A476E S673D 突变:A476E S673D 突变:A476E S673D 突变:A476E S673D ZN ZINC ION × 3 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;1 to 1 mixture of: Reservoir: 14% PEG 8K; 0.1M Na Acetate; 0.1 M Zn Acetate. Protein: 10 mg/ml 0.01 M Na HEPES pH 7.0; 0.02 M NaCl; 0.01 M Na Glutamate; 0.001 M EDTA, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.54 Å R-free 0.227
2GFE Crystal structure of the GluR2 A476E S673D Ligand Binding Core Mutant at 1.54 Angstroms Resolution 提交 2006-03-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–795(143 aa)
突变:A476E S673D 突变:A476E S673D ZN ZINC ION × 2 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;1 to 1 mixture of: Reservoir: 14% PEG 8K; 0.1M Na Acetate; 0.1 M Zn Acetate. Protein: 10 mg/ml 0.01 M Na HEPES pH 7.0; 0.02 M NaCl; 0.01 M Na Glutamate; 0.001 M EDTA, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.54 Å R-free 0.227
2GFE Crystal structure of the GluR2 A476E S673D Ligand Binding Core Mutant at 1.54 Angstroms Resolution 提交 2006-03-21 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–795(143 aa)
链 B 413–527(115 aa)
链 B 653–795(143 aa)
链 C 413–527(115 aa)
链 C 653–795(143 aa)
突变:A476E S673D 突变:A476E S673D 突变:A476E S673D 突变:A476E S673D 突变:A476E S673D 突变:A476E S673D ZN ZINC ION × 5 GLU GLUTAMIC ACID × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;1 to 1 mixture of: Reservoir: 14% PEG 8K; 0.1M Na Acetate; 0.1 M Zn Acetate. Protein: 10 mg/ml 0.01 M Na HEPES pH 7.0; 0.02 M NaCl; 0.01 M Na Glutamate; 0.001 M EDTA, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.54 Å R-free 0.227
2GFE Crystal structure of the GluR2 A476E S673D Ligand Binding Core Mutant at 1.54 Angstroms Resolution 提交 2006-03-21 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–795(143 aa)
链 B 413–527(115 aa)
链 B 653–795(143 aa)
突变:A476E S673D 突变:A476E S673D 突变:A476E S673D 突变:A476E S673D ZN ZINC ION × 3 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;1 to 1 mixture of: Reservoir: 14% PEG 8K; 0.1M Na Acetate; 0.1 M Zn Acetate. Protein: 10 mg/ml 0.01 M Na HEPES pH 7.0; 0.02 M NaCl; 0.01 M Na Glutamate; 0.001 M EDTA, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.54 Å R-free 0.227
2I3V Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of G725C mutant 提交 2006-08-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 2 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1 M CACODYLATE, 18% PEG 8000, 0.2 M ZINC ACETATE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 2.40 Å R-free 0.281
2I3V Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of G725C mutant 提交 2006-08-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1 M CACODYLATE, 18% PEG 8000, 0.2 M ZINC ACETATE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 2.40 Å R-free 0.281
2I3V Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of G725C mutant 提交 2006-08-21 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 1 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1 M CACODYLATE, 18% PEG 8000, 0.2 M ZINC ACETATE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 2.40 Å R-free 0.281
2I3V Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of G725C mutant 提交 2006-08-21 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 D 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 1 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1 M CACODYLATE, 18% PEG 8000, 0.2 M ZINC ACETATE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 2.40 Å R-free 0.281
2I3V Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of G725C mutant 提交 2006-08-21 Assembly 5 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 D 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 D 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 7 GLU GLUTAMIC ACID × 4 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1 M CACODYLATE, 18% PEG 8000, 0.2 M ZINC ACETATE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 2.40 Å R-free 0.281
2I3V Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of G725C mutant 提交 2006-08-21 Assembly 6 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 D 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 D 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1 M CACODYLATE, 18% PEG 8000, 0.2 M ZINC ACETATE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 2.40 Å R-free 0.281
2I3V Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of G725C mutant 提交 2006-08-21 Assembly 7 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 C 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 3 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1 M CACODYLATE, 18% PEG 8000, 0.2 M ZINC ACETATE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 2.40 Å R-free 0.281
2I3V Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of G725C mutant 提交 2006-08-21 Assembly 8 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 D 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 D 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
未记录 ZN ZINC ION × 4 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;0.1 M CACODYLATE, 18% PEG 8000, 0.2 M ZINC ACETATE, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 2.40 Å R-free 0.281
2I3W Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of S729C mutant 提交 2006-08-21 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
突变:G729C 突变:G729C GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.1 M CITRATE 20% PEG 3000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.30 Å R-free 0.284
2I3W Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of S729C mutant 提交 2006-08-21 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
突变:G729C 突变:G729C GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.1 M CITRATE 20% PEG 3000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.30 Å R-free 0.284
2I3W Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: Structure of S729C mutant 提交 2006-08-21 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 A 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 413–527(115 aa) 片段:LIGAND BINDING CORE (S1S2J)
链 B 653–794(142 aa) 片段:LIGAND BINDING CORE (S1S2J)
突变:G729C 突变:G729C 突变:G729C 突变:G729C GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;0.1 M CITRATE 20% PEG 3000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.30 Å R-free 0.284
2P2A X-ray structure of the GluR2 ligand binding core (S1S2J) in complex with 2-Bn-tet-AMPA at 2.26A resolution 提交 2007-03-07 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:GluR2-Flop ligand-binding core (Residues 413-527, 653-796)
链 A 653–796(144 aa) 片段:GluR2-Flop ligand-binding core (Residues 413-527, 653-796)
链 B 413–527(115 aa) 片段:GluR2-Flop ligand-binding core (Residues 413-527, 653-796)
链 B 653–796(144 aa) 片段:GluR2-Flop ligand-binding core (Residues 413-527, 653-796)
未记录 SO4 SULFATE ION × 3 GLU GLUTAMIC ACID × 1 MP9 2-AMINO-3-[3-HYDROXY-5-(2-BENZYL-2H-5-TETRAZOLYL)-4-ISOXAZOLYL]-PROPIONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;280 K;PEG4000, Sodium Acetate, Ammonium Sulfate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.26 Å R-free 0.273
2XX7 Crystal structure of 1-(4-(1-pyrrolidinylcarbonyl)phenyl)-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 2.2A resolution. 提交 2010-11-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-795
链 A 653–795(143 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-795
链 C 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-795
链 C 653–795(143 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-795
突变:YES 突变:YES 突变:YES 突变:YES GLU GLUTAMIC ACID × 2 1ND 1-[4-(1-PYRROLIDINYLCARBONYL)PHENYL]-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOLE × 1 ZN ZINC ION × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.20 Å R-free 0.218
2XX7 Crystal structure of 1-(4-(1-pyrrolidinylcarbonyl)phenyl)-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 2.2A resolution. 提交 2010-11-09 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-795
链 B 653–795(143 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-795
突变:YES 突变:YES GLU GLUTAMIC ACID × 2 1ND 1-[4-(1-PYRROLIDINYLCARBONYL)PHENYL]-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOLE × 2 SO4 SULFATE ION × 2 ZN ZINC ION × 6 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.20 Å R-free 0.218
2XX8 Crystal structure of N,N-dimethyl-4-(3-(trifluoromethyl)-4,5,6,7- tetrahydro-1H-indazol-1-yl)benzamide in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 2.2A resolution. 提交 2010-11-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 A 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 C 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 C 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
突变:YES 突变:YES 突变:YES 突变:YES GLU GLUTAMIC ACID × 2 1NE N,N-DIMETHYL-4-[3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL]BENZAMIDE × 1 ZN ZINC ION × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.55 Å R-free 0.212
2XX8 Crystal structure of N,N-dimethyl-4-(3-(trifluoromethyl)-4,5,6,7- tetrahydro-1H-indazol-1-yl)benzamide in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 2.2A resolution. 提交 2010-11-09 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 B 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
突变:YES 突变:YES GLU GLUTAMIC ACID × 2 1NE N,N-DIMETHYL-4-[3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL]BENZAMIDE × 2 SO4 SULFATE ION × 2 ZN ZINC ION × 6 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.55 Å R-free 0.212
2XX9 Crystal structure of 1-((2-fluoro-4-(3-(trifluoromethyl)-4,5,6,7- tetrahydro-1H-indazol-1-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 2.2A resolution. 提交 2010-11-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 B 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
突变:YES 突变:YES GLU GLUTAMIC ACID × 2 1NF N,N-DIMETHYL-4-[3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL]BENZAMIDE × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.97 Å R-free 0.224
2XX9 Crystal structure of 1-((2-fluoro-4-(3-(trifluoromethyl)-4,5,6,7- tetrahydro-1H-indazol-1-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 2.2A resolution. 提交 2010-11-09 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 A 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 C 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 C 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
突变:YES 突变:YES 突变:YES 突变:YES GLU GLUTAMIC ACID × 2 1NF N,N-DIMETHYL-4-[3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL]BENZAMIDE × 1 SO4 SULFATE ION × 1 ZN ZINC ION × 3 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.97 Å R-free 0.224
2XXH Crystal structure of 1-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)phenyl)-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 1.5A resolution. 提交 2010-11-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 B 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
突变:YES 突变:YES GLU GLUTAMIC ACID × 2 1NG 1-{4-[2-OXO-2-(1-PYRROLIDINYL)ETHYL]PHENYL}-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOLE × 2 SO4 SULFATE ION × 2 ZN ZINC ION × 6 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.50 Å R-free 0.218
2XXH Crystal structure of 1-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)phenyl)-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 1.5A resolution. 提交 2010-11-10 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 A 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 C 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 C 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
突变:YES 突变:YES 突变:YES 突变:YES GLU GLUTAMIC ACID × 2 1NG 1-{4-[2-OXO-2-(1-PYRROLIDINYL)ETHYL]PHENYL}-3-( TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOLE × 1 ZN ZINC ION × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.50 Å R-free 0.218
2XXI Crystal structure of 1-((4-(3-(trifluoromethyl)-6,7-dihydropyrano(4,3- c(pyrazol-1(4H)-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 1.6A resolution. 提交 2010-11-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 A 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 C 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 C 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
突变:YES 突变:YES 突变:YES 突变:YES GLU GLUTAMIC ACID × 2 JAC 1-({4-[3-(TRIFLUOROMETHYL)-6,7-DIHYDROPYRANO[4,3-C]PYRAZOL-1(4H)-YL]PHENYL}METHYL)-2-PYRROLIDINONE × 1 SO4 SULFATE ION × 1 ZN ZINC ION × 3 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.60 Å R-free 0.208
2XXI Crystal structure of 1-((4-(3-(trifluoromethyl)-6,7-dihydropyrano(4,3- c(pyrazol-1(4H)-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 1.6A resolution. 提交 2010-11-10 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
链 B 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, RESIDUES 413-527,653-796
突变:YES 突变:YES GLU GLUTAMIC ACID × 2 JAC 1-({4-[3-(TRIFLUOROMETHYL)-6,7-DIHYDROPYRANO[4,3-C]PYRAZOL-1(4H)-YL]PHENYL}METHYL)-2-PYRROLIDINONE × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.60 Å R-free 0.208
3B6Q Crystal Structure of the GLUR2 Ligand Binding Core (S1S2J) Mutant T686A in Complex with Glutamate at 2.0 Resolution 提交 2007-10-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
突变:T686A 突变:T686A SO4 SULFATE ION × 2 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 8.5;293 K;0.1 M Tris-HCl, 0.15-0.2 M lithium sulfate, 18-21% PEG4000, pH 8.5, VAPOR DIFFUSION, temperature 293K
分辨率 2.00 Å R-free 0.222
3B6T Crystal Structure of the GLUR2 Ligand Binding Core (S1S2J) T686A Mutant in Complex with Quisqualate at 2.1 Resolution 提交 2007-10-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
突变:T686A 突变:T686A SO4 SULFATE ION × 2 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Tris-HCl, 0.15-0.2 M lithium sulfate, 18-21% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.10 Å R-free 0.274
3B6W Crystal Structure of the GLUR2 Ligand Binding Core (S1S2J) T686S Mutant in Complex with Glutamate at 1.7 Resolution 提交 2007-10-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
链 C 413–527(115 aa)
链 C 653–796(144 aa)
突变:T686S 突变:T686S 突变:T686S 突变:T686S SO4 SULFATE ION × 3 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Tris-HCl, 0.15-0.2 M lithium sulfate, 18-21% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 1.70 Å R-free 0.260
3B6W Crystal Structure of the GLUR2 Ligand Binding Core (S1S2J) T686S Mutant in Complex with Glutamate at 1.7 Resolution 提交 2007-10-29 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–796(144 aa)
链 D 413–527(115 aa)
链 D 653–796(144 aa)
突变:T686S 突变:T686S 突变:T686S 突变:T686S SO4 SULFATE ION × 1 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M Tris-HCl, 0.15-0.2 M lithium sulfate, 18-21% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 1.70 Å R-free 0.260
3B7D Crystal structure of the GLUR2 ligand binding core (HS1S2J) in complex with CNQX at 2.5 A resolution 提交 2007-10-30 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–794(142 aa)
链 B 413–527(115 aa)
链 B 653–794(142 aa)
未记录 CNI 7-nitro-2,3-dioxo-2,3-dihydroquinoxaline-6-carbonitrile × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;40 mM Sodium citrate, 10 mM Ammonium sulfate, 1% PEG 400, pH 6.5, VAPOR DIFFUSION, HANGING DROP
分辨率 2.50 Å R-free 0.283
3B7D Crystal structure of the GLUR2 ligand binding core (HS1S2J) in complex with CNQX at 2.5 A resolution 提交 2007-10-30 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa)
链 C 653–794(142 aa)
链 D 413–527(115 aa)
链 D 653–794(142 aa)
未记录 CNI 7-nitro-2,3-dioxo-2,3-dihydroquinoxaline-6-carbonitrile × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;40 mM Sodium citrate, 10 mM Ammonium sulfate, 1% PEG 400, pH 6.5, VAPOR DIFFUSION, HANGING DROP
分辨率 2.50 Å R-free 0.283
3B7D Crystal structure of the GLUR2 ligand binding core (HS1S2J) in complex with CNQX at 2.5 A resolution 提交 2007-10-30 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 413–527(115 aa)
链 E 653–794(142 aa)
链 F 413–527(115 aa)
链 F 653–794(142 aa)
未记录 CNI 7-nitro-2,3-dioxo-2,3-dihydroquinoxaline-6-carbonitrile × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;40 mM Sodium citrate, 10 mM Ammonium sulfate, 1% PEG 400, pH 6.5, VAPOR DIFFUSION, HANGING DROP
分辨率 2.50 Å R-free 0.283
3B7D Crystal structure of the GLUR2 ligand binding core (HS1S2J) in complex with CNQX at 2.5 A resolution 提交 2007-10-30 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 G 413–527(115 aa)
链 G 653–794(142 aa)
链 H 413–527(115 aa)
链 H 653–794(142 aa)
未记录 CNI 7-nitro-2,3-dioxo-2,3-dihydroquinoxaline-6-carbonitrile × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;40 mM Sodium citrate, 10 mM Ammonium sulfate, 1% PEG 400, pH 6.5, VAPOR DIFFUSION, HANGING DROP
分辨率 2.50 Å R-free 0.283
3BBR Crystal structure of the iGluR2 ligand binding core (S1S2J-N775S) in complex with a dimeric positive modulator as well as glutamate at 2.25 A resolution 提交 2007-11-11 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding core
链 A 653–796(144 aa) 片段:Ligand binding core
链 B 413–527(115 aa) 片段:Ligand binding core
链 B 653–796(144 aa) 片段:Ligand binding core
突变:N775S 突变:N775S 突变:N775S 突变:N775S SO4 SULFATE ION × 5 CL CHLORIDE ION × 1 GLU GLUTAMIC ACID × 2 BHY N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide × 1 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;280 K;0.3M ammonium sulfate, 0.1M sodium acetate, 25% PEG 4000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.25 Å R-free 0.231
3BFT Structure of the ligand-binding core of GluR2 in complex with the agonist (S)-TDPA at 2.25 A resolution 提交 2007-11-23 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:residues 1-263
链 A 653–796(144 aa) 片段:residues 1-263
链 C 413–527(115 aa) 片段:residues 1-263
链 C 653–796(144 aa) 片段:residues 1-263
未记录 S2P (2S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propanoic acid × 2 ZN ZINC ION × 2 NA SODIUM ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 2000, cacodylate, zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.27 Å R-free 0.250
3BFT Structure of the ligand-binding core of GluR2 in complex with the agonist (S)-TDPA at 2.25 A resolution 提交 2007-11-23 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:residues 1-263
链 B 653–796(144 aa) 片段:residues 1-263
未记录 S2P (2S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propanoic acid × 2 ZN ZINC ION × 6 NA SODIUM ION × 2 CAC CACODYLATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 2000, cacodylate, zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.27 Å R-free 0.250
3BFU Structure of the ligand-binding core of GluR2 in complex with the agonist (R)-TDPA at 1.95 A resolution 提交 2007-11-23 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:residues 1-263
链 A 653–796(144 aa) 片段:residues 1-263
未记录 R2P (2R)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propanoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 2000, cacodylate, ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.95 Å R-free 0.233
3BFU Structure of the ligand-binding core of GluR2 in complex with the agonist (R)-TDPA at 1.95 A resolution 提交 2007-11-23 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:residues 1-263
链 B 653–796(144 aa) 片段:residues 1-263
未记录 R2P (2R)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propanoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 2000, cacodylate, ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.95 Å R-free 0.233
3BFU Structure of the ligand-binding core of GluR2 in complex with the agonist (R)-TDPA at 1.95 A resolution 提交 2007-11-23 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa) 片段:residues 1-263
链 C 653–796(144 aa) 片段:residues 1-263
未记录 R2P (2R)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propanoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 2000, cacodylate, ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.95 Å R-free 0.233
3BFU Structure of the ligand-binding core of GluR2 in complex with the agonist (R)-TDPA at 1.95 A resolution 提交 2007-11-23 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 413–527(115 aa) 片段:residues 1-263
链 D 653–796(144 aa) 片段:residues 1-263
未记录 R2P (2R)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propanoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;PEG 2000, cacodylate, ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.95 Å R-free 0.233
3BKI Crystal Structure of the GluR2 ligand binding core (S1S2J) in complex with FQX at 1.87 Angstroms 提交 2007-12-06 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 P 413–527(115 aa)
链 P 653–796(144 aa)
未记录 FQX [1,2,5]oxadiazolo[3,4-g]quinoxaline-6,7(5H,8H)-dione 1-oxide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
分辨率 1.87 Å R-free 0.221
3BKI Crystal Structure of the GluR2 ligand binding core (S1S2J) in complex with FQX at 1.87 Angstroms 提交 2007-12-06 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–796(144 aa)
未记录 FQX [1,2,5]oxadiazolo[3,4-g]quinoxaline-6,7(5H,8H)-dione 1-oxide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
分辨率 1.87 Å R-free 0.221
3BKI Crystal Structure of the GluR2 ligand binding core (S1S2J) in complex with FQX at 1.87 Angstroms 提交 2007-12-06 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 413–527(115 aa)
链 C 653–796(144 aa)
未记录 FQX [1,2,5]oxadiazolo[3,4-g]quinoxaline-6,7(5H,8H)-dione 1-oxide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
分辨率 1.87 Å R-free 0.221
3BKI Crystal Structure of the GluR2 ligand binding core (S1S2J) in complex with FQX at 1.87 Angstroms 提交 2007-12-06 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 413–527(115 aa)
链 D 653–796(144 aa)
未记录 FQX [1,2,5]oxadiazolo[3,4-g]quinoxaline-6,7(5H,8H)-dione 1-oxide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
分辨率 1.87 Å R-free 0.221
3DP6 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to glutamate 提交 2008-07-07 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:S1S2 binding domain
链 A 653–796(144 aa) 片段:S1S2 binding domain
未记录 ZN ZINC ION × 2 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;14-17% PEG 8000, 0.1-0.2 M Zn acetate, 0.1 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 1.55 Å R-free 0.244
3DP6 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to glutamate 提交 2008-07-07 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:S1S2 binding domain
链 B 653–796(144 aa) 片段:S1S2 binding domain
未记录 ZN ZINC ION × 2 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;14-17% PEG 8000, 0.1-0.2 M Zn acetate, 0.1 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 1.55 Å R-free 0.244
3DP6 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to glutamate 提交 2008-07-07 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 413–527(115 aa) 片段:S1S2 binding domain
链 C 653–796(144 aa) 片段:S1S2 binding domain
未记录 ZN ZINC ION × 2 GLU GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;277 K;14-17% PEG 8000, 0.1-0.2 M Zn acetate, 0.1 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.50
分辨率 1.55 Å R-free 0.244
3H03 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to UBP277 提交 2009-04-08 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 A 653–794(142 aa) 片段:UNP residues 414-527, 652-794
链 B 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 B 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 UBP 3-[3-(2-carboxyethyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-L-alanine × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-16% PEG8K, 0.1-0.15 M Zn acetate, 0.25 M ammonium sulfate, 0.1 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.258
3H03 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to UBP277 提交 2009-04-08 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 D 653–794(142 aa) 片段:UNP residues 414-527, 652-794
链 G 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 G 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 UBP 3-[3-(2-carboxyethyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-L-alanine × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-16% PEG8K, 0.1-0.15 M Zn acetate, 0.25 M ammonium sulfate, 0.1 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.258
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 G 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 G 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 10 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 E 653–794(142 aa) 片段:UNP residues 414-527, 652-794
链 P 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 P 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 11 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 G 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 G 653–794(142 aa) 片段:UNP residues 414-527, 652-794
链 J 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 J 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 12 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 H 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 H 653–794(142 aa) 片段:UNP residues 414-527, 652-794
链 L 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 L 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 B 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 E 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 E 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 H 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 H 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 J 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 J 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 L 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 L 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 7 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 N 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 N 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 8 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 P 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 P 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H06 Crystal structure of the binding domain of the AMPA subunit GluR2 bound to the willardiine antagonist, UBP282 提交 2009-04-08 Assembly 9 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 B 653–794(142 aa) 片段:UNP residues 414-527, 652-794
链 N 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 N 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 VBP 4-({3-[(2R)-2-amino-2-carboxyethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}methyl)benzoic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;15-17% PEG8K, 0.2 M Na acetate, 0.2 M Na cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.80 Å R-free 0.295
3H5V Crystal structure of the GluR2-ATD 提交 2009-04-22 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 0–383(384 aa) 片段:UNP residues 21-404
链 B 0–383(384 aa) 片段:UNP residues 21-404
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;14-16% PEG3350, 100mM TrisHCl, 10mM MgCl2, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.33 Å R-free 0.235
3H5V Crystal structure of the GluR2-ATD 提交 2009-04-22 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 0–383(384 aa) 片段:UNP residues 21-404
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;14-16% PEG3350, 100mM TrisHCl, 10mM MgCl2, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.33 Å R-free 0.235
3H5W Crystal structure of the GluR2-ATD in space group P212121 without solvent 提交 2009-04-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 0–383(384 aa) 片段:UNP residues 21-404
链 B 0–383(384 aa) 片段:UNP residues 21-404
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;20% PEG3000, 100mM tri-sodium citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.69 Å R-free 0.291
3H6T Crystal structure of the iGluR2 ligand-binding core (S1S2J-N754S) in complex with glutamate and cyclothiazide at 2.25 A resolution 提交 2009-04-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 A 653–796(144 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 C 413–527(115 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 C 653–796(144 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
突变:N754S 突变:N754S 突变:N754S 突变:N754S GLU GLUTAMIC ACID × 2 CYZ CYCLOTHIAZIDE × 2 ZN ZINC ION × 5 GOL GLYCEROL × 6 ACT ACETATE ION × 2 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;279 K;25 % PEG 4000, 0.3 M Zinc acetate, 0.1 M Cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.25 Å R-free 0.228
3H6T Crystal structure of the iGluR2 ligand-binding core (S1S2J-N754S) in complex with glutamate and cyclothiazide at 2.25 A resolution 提交 2009-04-24 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 B 653–796(144 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
突变:N754S 突变:N754S GLU GLUTAMIC ACID × 2 CYZ CYCLOTHIAZIDE × 2 ZN ZINC ION × 10 GOL GLYCEROL × 6 CAC CACODYLATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;279 K;25 % PEG 4000, 0.3 M Zinc acetate, 0.1 M Cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.25 Å R-free 0.228
3H6U Crystal structure of the iGluR2 ligand-binding core (S1S2J-N754S) in complex with glutamate and NS1493 at 1.85 A resolution 提交 2009-04-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 A 653–796(144 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
突变:N754S 突变:N754S GLU GLUTAMIC ACID × 2 NS3 (3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 SO4 SULFATE ION × 12 GOL GLYCEROL × 4 FLC CITRATE ANION × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 4.5;279 K;25 % PEG 8000, 0.1 M Lithium sulfate, 0.1 M Phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.85 Å R-free 0.215
3H6V Crystal structure of the iGluR2 ligand-binding core (S1S2J-N754S) in complex with glutamate and NS5206 at 2.10 A resolution 提交 2009-04-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 A 653–796(144 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 B 413–527(115 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 B 653–796(144 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
突变:N754S 突变:N754S 突变:N754S 突变:N754S GLU GLUTAMIC ACID × 2 NS6 (3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide × 2 GOL GLYCEROL × 2 SO4 SULFATE ION × 7 DMS DIMETHYL SULFOXIDE × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 4.5;279 K;20 % PEG 4000, 0.3 M Lithium sulfate, 0.1 M Phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.10 Å R-free 0.228
3H6W Crystal structure of the iGluR2 ligand-binding core (S1S2J-N754S) in complex with glutamate and NS5217 at 1.50 A resolution 提交 2009-04-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 A 653–796(144 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
突变:N754S 突变:N754S GLU GLUTAMIC ACID × 2 NS7 (3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide × 2 SO4 SULFATE ION × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;20 % PEG 4000, 0.1 M Ammonium sulfate, 0.1 M Cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.49 Å R-free 0.232
3H6W Crystal structure of the iGluR2 ligand-binding core (S1S2J-N754S) in complex with glutamate and NS5217 at 1.50 A resolution 提交 2009-04-24 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
链 B 653–796(144 aa) 片段:iGluR2-flop ligand-binding core: UNP residues 413-796
突变:N754S 突变:N754S GLU GLUTAMIC ACID × 2 NS7 (3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide × 2 SO4 SULFATE ION × 2 DMS DIMETHYL SULFOXIDE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;20 % PEG 4000, 0.1 M Ammonium sulfate, 0.1 M Cacodylate pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.49 Å R-free 0.232
3HSY High resolution structure of a dimeric GluR2 N-terminal domain (NTD) 提交 2009-06-11 Assembly 1 其他组合 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 25–400(376 aa) 片段:N-terminal Domain, UNP residues 25-400
链 B 25–400(376 aa) 片段:N-terminal Domain, UNP residues 25-400
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.8;293 K;200mM ammonium phosphatre, 20% PEG3350, pH4.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K
分辨率 1.75 Å R-free 0.205
3IJO Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, althiazide 提交 2009-08-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa)
链 B 653–794(142 aa)
链 E 414–527(114 aa)
链 E 653–794(142 aa)
未记录 GLU GLUTAMIC ACID × 2 B4D (3S)-6-chloro-3-[(prop-2-en-1-ylsulfanyl)methyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide × 2 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.00 Å R-free 0.234
3IJO Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, althiazide 提交 2009-08-04 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 H 414–527(114 aa)
链 H 653–794(142 aa)
未记录 GLU GLUTAMIC ACID × 2 B4D (3S)-6-chloro-3-[(prop-2-en-1-ylsulfanyl)methyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.00 Å R-free 0.234
3IJX Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, hydrochlorothiazide 提交 2009-08-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa)
链 B 653–794(142 aa)
链 D 414–527(114 aa)
链 D 653–794(142 aa)
未记录 GLU GLUTAMIC ACID × 2 HCZ 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.88 Å R-free 0.257
3IJX Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, hydrochlorothiazide 提交 2009-08-05 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 H 414–527(114 aa)
链 H 653–794(142 aa)
未记录 GLU GLUTAMIC ACID × 2 HCZ 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide × 2 ZN ZINC ION × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.88 Å R-free 0.257
3IK6 Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, chlorothiazide 提交 2009-08-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 B 414–527(114 aa) 片段:S1S2 binding domain
链 B 653–794(142 aa) 片段:S1S2 binding domain
链 E 414–527(114 aa) 片段:S1S2 binding domain
链 E 653–794(142 aa) 片段:S1S2 binding domain
链 H 414–527(114 aa) 片段:S1S2 binding domain
链 H 653–794(142 aa) 片段:S1S2 binding domain
未记录 GLU GLUTAMIC ACID × 3 HCZ 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide × 3 ZN ZINC ION × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.10 Å R-free 0.245
3IL1 Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, IDRA-21 提交 2009-08-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:S1S2 binding domain
链 B 653–794(142 aa) 片段:S1S2 binding domain
链 E 414–527(114 aa) 片段:S1S2 binding domain
链 E 653–794(142 aa) 片段:S1S2 binding domain
突变:N242S 突变:N242S 突变:N242S 突变:N242S GLU GLUTAMIC ACID × 2 ZN ZINC ION × 3 B5D (3S)-7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.00 Å R-free 0.234
3IL1 Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, IDRA-21 提交 2009-08-06 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 H 414–527(114 aa) 片段:S1S2 binding domain
链 H 653–794(142 aa) 片段:S1S2 binding domain
突变:N242S 突变:N242S GLU GLUTAMIC ACID × 2 ZN ZINC ION × 4 B5D (3S)-7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.00 Å R-free 0.234
3ILT Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, trichlormethiazide 提交 2009-08-07 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 B 414–527(114 aa) 片段:S1S2 binding domain
链 B 653–794(142 aa) 片段:S1S2 binding domain
链 E 414–527(114 aa) 片段:S1S2 binding domain
链 E 653–794(142 aa) 片段:S1S2 binding domain
链 H 414–527(114 aa) 片段:S1S2 binding domain
链 H 653–794(142 aa) 片段:S1S2 binding domain
突变:N242S 突变:N242S 突变:N242S 突变:N242S 突变:N242S 突变:N242S GLU GLUTAMIC ACID × 3 ZN ZINC ION × 5 TRU 6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.11 Å R-free 0.261
3ILU Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, hydroflumethiazide 提交 2009-08-07 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:S1S2 binding domain
链 B 653–794(142 aa) 片段:S1S2 binding domain
链 E 414–527(114 aa) 片段:S1S2 binding domain
链 E 653–794(142 aa) 片段:S1S2 binding domain
突变:N242S 突变:N242S 突变:N242S 突变:N242S GLU GLUTAMIC ACID × 2 HFZ 6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.00 Å R-free 0.226
3ILU Crystal structure of the AMPA subunit GluR2 bound to the allosteric modulator, hydroflumethiazide 提交 2009-08-07 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 H 414–527(114 aa) 片段:S1S2 binding domain
链 H 653–794(142 aa) 片段:S1S2 binding domain
突变:N242S 突变:N242S GLU GLUTAMIC ACID × 2 HFZ 6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18 PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 zinc acetate, pH 6.5, vapor diffusion, hanging drop, temperature 277K
分辨率 2.00 Å R-free 0.226
3KG2 AMPA subtype ionotropic glutamate receptor in complex with competitive antagonist ZK 200775 提交 2009-10-28 Assembly 1 其他组合 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa) 片段:sequence database residues 25-847
链 B 25–847(823 aa) 片段:sequence database residues 25-847
链 C 25–847(823 aa) 片段:sequence database residues 25-847
链 D 25–847(823 aa) 片段:sequence database residues 25-847
突变:N241E, N385D, N392Q, K410A, E413A, M414A, E416A, and C589A 突变:N241E, N385D, N392Q, K410A, E413A, M414A, E416A, and C589A 突变:N241E, N385D, N392Q, K410A, E413A, M414A, E416A, and C589A 突变:N241E, N385D, N392Q, K410A, E413A, M414A, E416A, and C589A ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 X-RAY DIFFRACTION
X-ray结晶条件 277 K;Under paraffin oil, temperature 277K
分辨率 3.60 Å R-free 0.296
3KGC Isolated ligand binding domain dimer of GluA2 ionotropic glutamate receptor in complex with glutamate, LY 404187 and ZK 200775 提交 2009-10-28 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 414–527(114 aa) 片段:extracellular domains residues 414-527 and 653-795
链 A 654–795(142 aa) 片段:extracellular domains residues 414-527 and 653-795
链 B 414–527(114 aa) 片段:extracellular domains residues 414-527 and 653-795
链 B 654–795(142 aa) 片段:extracellular domains residues 414-527 and 653-795
未记录 GLU GLUTAMIC ACID × 1 SO4 SULFATE ION × 2 LY7 N-[(2S)-2-(4'-cyanobiphenyl-4-yl)propyl]propane-2-sulfonamide × 1 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;19% PEG 4000, 0.3 M ammonium sulfate, 0.1 M sodium acetate, pH 5.0, vapor diffusion, hanging drop, temperature 277K
分辨率 1.55 Å R-free 0.224
3LSF Piracetam bound to the ligand binding domain of GluA2 提交 2010-02-12 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa)
链 B 653–794(142 aa)
链 E 414–527(114 aa)
链 E 653–794(142 aa)
突变:N242S 突变:N242S 突变:N242S 突变:N242S GLU GLUTAMIC ACID × 2 PZI 2-(2-oxopyrrolidin-1-yl)acetamide × 4 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18% PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 M zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.85 Å R-free 0.228
3LSF Piracetam bound to the ligand binding domain of GluA2 提交 2010-02-12 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 H 414–527(114 aa)
链 H 653–794(142 aa)
突变:N242S 突变:N242S GLU GLUTAMIC ACID × 2 PZI 2-(2-oxopyrrolidin-1-yl)acetamide × 4 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18% PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 M zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.85 Å R-free 0.228
3LSL Piracetam bound to the ligand binding domain of GluA2 (flop form) 提交 2010-02-12 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 414–527(114 aa)
链 A 653–794(142 aa)
链 D 414–527(114 aa)
链 D 653–794(142 aa)
未记录 GLU GLUTAMIC ACID × 2 PZI 2-(2-oxopyrrolidin-1-yl)acetamide × 6 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18% PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 M zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.12 Å R-free 0.263
3LSL Piracetam bound to the ligand binding domain of GluA2 (flop form) 提交 2010-02-12 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 G 414–527(114 aa)
链 G 653–794(142 aa)
未记录 GLU GLUTAMIC ACID × 2 PZI 2-(2-oxopyrrolidin-1-yl)acetamide × 6 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18% PEG8K, 0.1 M Na Cacodylate, 0.1-0.15 M zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.12 Å R-free 0.263
3M3L PEPA bound to the ligand binding domain of GluA2 (flop form) 提交 2010-03-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 A 653–794(142 aa) 片段:UNP residues 414-527, 652-794
链 D 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 D 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 GLU GLUTAMIC ACID × 2 P99 2-[2,6-difluoro-4-({2-[(phenylsulfonyl)amino]ethyl}sulfanyl)phenoxy]acetamide × 1 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG 8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.85 Å R-free 0.242
3M3L PEPA bound to the ligand binding domain of GluA2 (flop form) 提交 2010-03-09 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 G 414–527(114 aa) 片段:UNP residues 414-527, 652-794
链 G 653–794(142 aa) 片段:UNP residues 414-527, 652-794
未记录 GLU GLUTAMIC ACID × 2 P99 2-[2,6-difluoro-4-({2-[(phenylsulfonyl)amino]ethyl}sulfanyl)phenoxy]acetamide × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG 8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.85 Å R-free 0.242
3N6V Structure of the GluA2 NTD-dimer interface mutant, T78A 提交 2010-05-26 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 27–400(374 aa) 片段:N-terminal domain
链 B 27–400(374 aa) 片段:N-terminal domain
突变:T78A 突变:T78A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;100mM Tris, 200mM MgCl2, 20% PEG 8000, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 3.20 Å R-free 0.265
3N6V Structure of the GluA2 NTD-dimer interface mutant, T78A 提交 2010-05-26 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 27–400(374 aa) 片段:N-terminal domain
链 D 27–400(374 aa) 片段:N-terminal domain
突变:T78A 突变:T78A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;100mM Tris, 200mM MgCl2, 20% PEG 8000, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 3.20 Å R-free 0.265
3N6V Structure of the GluA2 NTD-dimer interface mutant, T78A 提交 2010-05-26 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 27–400(374 aa) 片段:N-terminal domain
链 F 27–400(374 aa) 片段:N-terminal domain
突变:T78A 突变:T78A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;291 K;100mM Tris, 200mM MgCl2, 20% PEG 8000, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 3.20 Å R-free 0.265
3O28 Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-07-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
链 A 653–795(143 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
未记录 O28 2-({[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetyl}amino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide × 2 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 6 DMS DIMETHYL SULFOXIDE × 2 GOL GLYCEROL × 12 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;16% PEG 8000, 100mM Sodium Cacodylate pH 4.5, 50mM Lithium Sulphate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.00 Å R-free 0.234
3O29 Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-07-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
链 A 653–795(143 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
未记录 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 4 GOL GLYCEROL × 8 O29 N-[2-(dimethylamino)ethyl]-2-({[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetyl}amino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;12% PEG 4000, 100mM Sodium Cacodylate pH 4.5, 50mM Lithium Sulphate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.02 Å R-free 0.250
3O2A Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-07-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
链 A 653–795(143 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
未记录 O30 N-(3-aminopropyl)-2-({[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetyl}amino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide × 2 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 4 GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;18% PEG 4000, 100mM Sodium Cacodylate pH 4.5, 50mM Lithium Sulphate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.90 Å R-free 0.217
3O2J Structure of the GluA2 NTD-dimer interface mutant, N54A 提交 2010-07-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 22–400(379 aa) 片段:N-terminal domain
链 B 22–400(379 aa) 片段:N-terminal domain
突变:N54A 突变:N54A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;291 K;18% PEG 3350, 100mM sodium citrate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 1.95 Å R-free 0.247
3O6G Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-07-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
链 A 653–795(143 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
未记录 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 6 O27 N-[(3R)-pyrrolidin-3-yl]-2-({[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetyl}amino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide × 2 EDO 1,2-ETHANEDIOL × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;277 K;17% PEG 4000, 100mM Sodium Cacodylate pH 4.0, 50mM Lithium Sulphate, 2.5% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.223
3O6H Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-07-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
链 A 653–795(143 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
未记录 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 6 O25 2-[({4-[(ethylamino)methyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl}acetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide × 2 DMS DIMETHYL SULFOXIDE × 2 EDO 1,2-ETHANEDIOL × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;277 K;18% PEG 4000, 100mM Sodium Cacodylate pH 4.0, 50mM Lithium Sulphate, 5% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.10 Å R-free 0.263
3O6I Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-07-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
链 A 653–795(143 aa) 片段:Ligand binding domain, UNP residues 413 to 527 and 653 to 796
未记录 GLU GLUTAMIC ACID × 2 O26 2-[({3-tert-butyl-4-[(methylamino)methyl]-1H-pyrazol-1-yl}acetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide × 2 SO4 SULFATE ION × 10 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.3;277 K;18% PEG 4000, 50mM Lithium sulphate, 2.5% Glycerol, 100mM Sodium Cacodylate pH 4.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.247
3PD8 X-ray structure of the ligand-binding core of GluA2 in complex with (S)-7-HPCA at 2.5 A resolution 提交 2010-10-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues 413-527, 653-795
链 A 653–795(143 aa) 片段:UNP residues 413-527, 653-795
链 B 413–527(115 aa) 片段:UNP residues 413-527, 653-795
链 B 653–795(143 aa) 片段:UNP residues 413-527, 653-795
未记录 ZN ZINC ION × 3 HA7 (7S)-3-hydroxy-4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-7-carboxylic acid × 2 GOL GLYCEROL × 1 ACY ACETIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;280 K;PEG4000, zinc acetate, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.48 Å R-free 0.261
3PD8 X-ray structure of the ligand-binding core of GluA2 in complex with (S)-7-HPCA at 2.5 A resolution 提交 2010-10-22 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa) 片段:UNP residues 413-527, 653-795
链 C 653–795(143 aa) 片段:UNP residues 413-527, 653-795
未记录 ZN ZINC ION × 4 HA7 (7S)-3-hydroxy-4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-7-carboxylic acid × 2 CAC CACODYLATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;280 K;PEG4000, zinc acetate, cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.48 Å R-free 0.261
3PD9 X-ray structure of the ligand-binding core of GluA2 in complex with (R)-5-HPCA at 2.1 A resolution 提交 2010-10-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues 413-527, 653-795
链 A 653–795(143 aa) 片段:UNP residues 413-527, 653-795
链 B 413–527(115 aa) 片段:UNP residues 413-527, 653-795
链 B 653–795(143 aa) 片段:UNP residues 413-527, 653-795
未记录 HA5 (5R)-3-hydroxy-4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-5-carboxylic acid × 2 SO4 SULFATE ION × 4 GOL GLYCEROL × 5 CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;280 K;PEG4000, ammonium sulfate, acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.10 Å R-free 0.233
3PMV Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-11-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, residues 413 to 527 and 653 to 796
链 A 653–796(144 aa) 片段:Ligand binding domain, residues 413 to 527 and 653 to 796
未记录 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 10 557 N-[(2S)-2-{4-[4-(hydroxymethyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}propyl]propane-2-sulfonamide × 2 GOL GLYCEROL × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;277 K;18% PEG 4000, 50mM Lithium Sulphate, 2.5% Glycerol, 100mM Sodium Cacodylate pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.80 Å R-free 0.252
3PMW Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-11-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, residues 413 to 527 and 653 to 796
链 A 653–796(144 aa) 片段:Ligand binding domain, residues 413 to 527 and 653 to 796
突变:S1-S2 fusion in which Gly118 and Thr119 replace a membrane-spanning region 突变:S1-S2 fusion in which Gly118 and Thr119 replace a membrane-spanning region GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 14 GOL GLYCEROL × 4 DMS DIMETHYL SULFOXIDE × 2 G69 N-[(2S)-5-{[4-(hydroxymethyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]methyl}-2,3-dihydro-1H-inden-2-yl]propane-2-sulfonami de × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;277 K;18% PEG 4000, 50mM Lithium Sulphate, 2.5% Glycerol, 100mM Sodium Cacodylate pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.20 Å R-free 0.313
3PMX Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2010-11-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, residues 413 to 527 and 653 to 796
链 A 653–796(144 aa) 片段:Ligand binding domain, residues 413 to 527 and 653 to 796
未记录 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 8 GOL GLYCEROL × 4 DMS DIMETHYL SULFOXIDE × 4 EDO 1,2-ETHANEDIOL × 8 808 N-[(2S)-5-{[5-(trifluoromethyl)furan-2-yl]methyl}-2,3-dihydro-1H-inden-2-yl]propane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4;277 K;18% PEG 4000, 50mM Lithium Sulphate, 2.5% Glycerol, 100mM Sodium Cacodylate pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.87 Å R-free 0.281
3RTF Chlorowillardiine bound to the ligand binding domain of GluA2 提交 2011-05-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:SEE REMARK 999
链 B 653–794(142 aa) 片段:SEE REMARK 999
链 D 414–527(114 aa) 片段:SEE REMARK 999
链 D 653–794(142 aa) 片段:SEE REMARK 999
未记录 CWD 3-(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alanine × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, 0.1 M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.203
3RTF Chlorowillardiine bound to the ligand binding domain of GluA2 提交 2011-05-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 414–527(114 aa) 片段:SEE REMARK 999
链 F 653–794(142 aa) 片段:SEE REMARK 999
未记录 CWD 3-(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alanine × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, 0.1 M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.70 Å R-free 0.203
3RTW Nitrowillardiine bound to the ligand binding domain of GluA2 提交 2011-05-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:SEE REMARK 999
链 B 653–794(142 aa) 片段:SEE REMARK 999
链 D 414–527(114 aa) 片段:SEE REMARK 999
链 D 653–794(142 aa) 片段:SEE REMARK 999
未记录 NWD 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alanine × 2 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, 0.1 M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.10 Å R-free 0.259
3RTW Nitrowillardiine bound to the ligand binding domain of GluA2 提交 2011-05-04 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 414–527(114 aa) 片段:SEE REMARK 999
链 F 653–794(142 aa) 片段:SEE REMARK 999
未记录 NWD 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alanine × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, 0.1 M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.10 Å R-free 0.259
3T93 Glutamate bound to a double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-02 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:SEE REMARK 999
链 B 653–794(142 aa) 片段:SEE REMARK 999
链 D 414–527(114 aa) 片段:SEE REMARK 999
链 D 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C GLU GLUTAMIC ACID × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.91 Å R-free 0.229
3T93 Glutamate bound to a double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-02 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 414–527(114 aa) 片段:SEE REMARK 999
链 F 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C GLU GLUTAMIC ACID × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.91 Å R-free 0.229
3T96 Iodowillardiine bound to a double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-02 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:SEE REMARK 999
链 B 653–794(142 aa) 片段:SEE REMARK 999
链 D 414–527(114 aa) 片段:SEE REMARK 999
链 D 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C IWD 2-AMINO-3-(5-IODO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.87 Å R-free 0.219
3T96 Iodowillardiine bound to a double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-02 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 414–527(114 aa) 片段:SEE REMARK 999
链 F 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C IWD 2-AMINO-3-(5-IODO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.87 Å R-free 0.219
3T9H Kainate bound to a double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-02 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:SEE REMARK 999
链 B 653–794(142 aa) 片段:SEE REMARK 999
链 D 414–527(114 aa) 片段:SEE REMARK 999
链 D 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.02 Å R-free 0.235
3T9H Kainate bound to a double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-02 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 414–527(114 aa) 片段:SEE REMARK 999
链 F 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.02 Å R-free 0.235
3T9U CNQX bound to an oxidized double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 414–527(114 aa) 片段:SEE REMARK 999
链 A 653–794(142 aa) 片段:SEE REMARK 999
链 B 414–527(114 aa) 片段:SEE REMARK 999
链 B 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C CNI 7-nitro-2,3-dioxo-2,3-dihydroquinoxaline-6-carbonitrile × 2 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.97 Å R-free 0.219
3T9U CNQX bound to an oxidized double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 414–527(114 aa) 片段:SEE REMARK 999
链 C 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C CNI 7-nitro-2,3-dioxo-2,3-dihydroquinoxaline-6-carbonitrile × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.97 Å R-free 0.219
3T9V CNQX bound to a reduced double cysteine mutant (A452C/S652C) of the ligand binding domain of GluA2 提交 2011-08-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 414–527(114 aa) 片段:SEE REMARK 999
链 A 653–794(142 aa) 片段:SEE REMARK 999
链 B 414–527(114 aa) 片段:SEE REMARK 999
链 B 653–794(142 aa) 片段:SEE REMARK 999
突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C 突变:A473C/S673C CNI 7-nitro-2,3-dioxo-2,3-dihydroquinoxaline-6-carbonitrile × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.98 Å R-free 0.238
3T9X Glutamate bound to a double cysteine mutant (V484C/E657C) of the ligand binding domain of GluA2 提交 2011-08-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:SEE REMARK 999
链 B 653–794(142 aa) 片段:SEE REMARK 999
链 F 414–527(114 aa) 片段:SEE REMARK 999
链 F 653–794(142 aa) 片段:SEE REMARK 999
突变:V505C/E678C 突变:V505C/E678C 突变:V505C/E678C 突变:V505C/E678C GLU GLUTAMIC ACID × 2 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.82 Å R-free 0.240
3T9X Glutamate bound to a double cysteine mutant (V484C/E657C) of the ligand binding domain of GluA2 提交 2011-08-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 414–527(114 aa) 片段:SEE REMARK 999
链 D 653–794(142 aa) 片段:SEE REMARK 999
突变:V505C/E678C 突变:V505C/E678C GLU GLUTAMIC ACID × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;14-15% PEG8000, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.82 Å R-free 0.240
3TDJ Crystal structure of the GluA2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and BPAM-97 at 1.95 A resolution 提交 2011-08-11 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP residues 413-527 and 653-796
链 A 653–796(144 aa) 片段:Ligand binding domain, UNP residues 413-527 and 653-796
链 B 413–527(115 aa) 片段:Ligand binding domain, UNP residues 413-527 and 653-796
链 B 653–796(144 aa) 片段:Ligand binding domain, UNP residues 413-527 and 653-796
突变:L483Y, N754S 突变:L483Y, N754S 突变:L483Y, N754S 突变:L483Y, N754S GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 3 CL CHLORIDE ION × 5 GOL GLYCEROL × 11 3TJ 4-ethyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;15.2% PEG4000, 0.3 M lithium sulfate and 0.1 M phosphate-citrate., pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.95 Å R-free 0.215
3TKD Crystal structure of the GluA2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and cyclothiazide at 1.45 A resolution 提交 2011-08-26 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain
链 A 653–795(143 aa) 片段:Ligand binding domain
链 B 413–527(115 aa) 片段:Ligand binding domain
链 B 653–795(143 aa) 片段:Ligand binding domain
突变:L483Y, N754S 突变:L483Y, N754S 突变:L483Y, N754S 突变:L483Y, N754S GLU GLUTAMIC ACID × 2 CYZ CYCLOTHIAZIDE × 2 SO4 SULFATE ION × 8 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;20% PEG4000, 0.3M ammonium sulfate, 0.1M phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.45 Å R-free 0.180
3TZA Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (S)-2-amino-3-(2-(2-carboxyethyl)-5-chloro-4-nitrophenyl)propionic acid at 1.9A resolution 提交 2011-09-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP resiudes 413-527,UNP residues 653-796
链 A 653–796(144 aa) 片段:Ligand binding domain, UNP resiudes 413-527,UNP residues 653-796
链 B 413–527(115 aa) 片段:Ligand binding domain, UNP resiudes 413-527,UNP residues 653-796
链 B 653–796(144 aa) 片段:Ligand binding domain, UNP resiudes 413-527,UNP residues 653-796
未记录 TZG (S)-2-amino-3-(2-(2-carboxyethyl)-5-chloro-4-nitrophenyl)propionic acid × 2 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;15.2% PEG4000, 0.1M ammonium sulfate, 0.1M sodium acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.90 Å R-free 0.230
4FAT Ligand-binding domain of GluA2 (flip) ionotropic glutamate receptor in complex with an allosteric modulator 提交 2012-05-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:ligand binding domain
链 A 653–796(144 aa) 片段:ligand binding domain
突变:delta 528-652 突变:delta 528-652 GLU GLUTAMIC ACID × 2 496 2-({[4-(hydroxymethyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}amino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide × 2 SO4 SULFATE ION × 6 GOL GLYCEROL × 8 LI LITHIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.1;298 K;18% PEG 4000, 50mM Lithium Sulphate, 100mM Sodium Cacodylate, pH 4.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 1.40 Å R-free 0.209
4G8M Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the agonist CBG-IV at 2.05A resolution 提交 2012-07-23 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues 413-527, 653-796
链 A 653–796(144 aa) 片段:UNP residues 413-527, 653-796
链 B 413–527(115 aa) 片段:UNP residues 413-527, 653-796
链 B 653–796(144 aa) 片段:UNP residues 413-527, 653-796
未记录 G8M (1S,2R)-2-[(S)-amino(carboxy)methyl]cyclobutanecarboxylic acid × 2 SO4 SULFATE ION × 7 CL CHLORIDE ION × 3 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;24.4% PEG4000, 0.3M lithium sulfate, 0.1M phosphate-citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.05 Å R-free 0.228
4G8M Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the agonist CBG-IV at 2.05A resolution 提交 2012-07-23 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues 413-527, 653-796
链 A 653–796(144 aa) 片段:UNP residues 413-527, 653-796
链 B 413–527(115 aa) 片段:UNP residues 413-527, 653-796
链 B 653–796(144 aa) 片段:UNP residues 413-527, 653-796
未记录 G8M (1S,2R)-2-[(S)-amino(carboxy)methyl]cyclobutanecarboxylic acid × 2 SO4 SULFATE ION × 7 CL CHLORIDE ION × 3 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;24.4% PEG4000, 0.3M lithium sulfate, 0.1M phosphate-citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.05 Å R-free 0.228
4GXS Ligand binding domain of GluA2 (AMPA/glutamate receptor) bound to (-)-kaitocephalin 提交 2012-09-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa) 片段:UNP Residues 652-794
链 B 653–794(142 aa) 片段:UNP Residues 652-794
链 D 414–527(114 aa) 片段:UNP Residues 652-794
链 D 653–794(142 aa) 片段:UNP Residues 652-794
未记录 0YS (5R)-2-[(1S,2R)-2-amino-2-carboxy-1-hydroxyethyl]-5-{(2S)-2-carboxy-2-[(3,5-dichloro-4-hydroxybenzoyl)amino]ethyl}-L-proline × 2 ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16-18% PEG 8K, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.96 Å R-free 0.225
4H8J Structure of GluA2-LBD in complex with MES 提交 2012-09-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:SEE REMARK 999
链 A 653–797(145 aa) 片段:SEE REMARK 999
链 B 413–527(115 aa) 片段:SEE REMARK 999
链 B 653–797(145 aa) 片段:SEE REMARK 999
未记录 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 SO4 SULFATE ION × 6 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;23-27% w/v PEG3350, 0.2 M lithium sulfate, MES sodium, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 1.80 Å R-free 0.221
4H8J Structure of GluA2-LBD in complex with MES 提交 2012-09-22 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa) 片段:SEE REMARK 999
链 C 653–797(145 aa) 片段:SEE REMARK 999
链 D 413–527(115 aa) 片段:SEE REMARK 999
链 D 653–797(145 aa) 片段:SEE REMARK 999
未记录 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 SO4 SULFATE ION × 6 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;23-27% w/v PEG3350, 0.2 M lithium sulfate, MES sodium, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 1.80 Å R-free 0.221
4IGT Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the agonist ZA302 at 1.24A resolution 提交 2012-12-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand-binding domain, UNP RESIDUES 413-527, 653-796
链 A 653–796(144 aa) 片段:Ligand-binding domain, UNP RESIDUES 413-527, 653-796
未记录 3ZA (4R)-4-{3-[hydroxy(methyl)amino]-3-oxopropyl}-L-glutamic acid × 2 SO4 SULFATE ION × 6 LI LITHIUM ION × 2 GOL GLYCEROL × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;15.2% PEG 4000, 0.1M Li2SO4, 0.1M phosphate-citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 1.24 Å R-free 0.155
4ISU Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (2R)-IKM-159 at 2.3A resolution. 提交 2013-01-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand-binding domain
链 A 653–796(144 aa) 片段:Ligand-binding domain
链 C 413–527(115 aa) 片段:Ligand-binding domain
链 C 653–796(144 aa) 片段:Ligand-binding domain
未记录 IKM (4aS,5aR,6R,8aS,8bS)-5a-(carboxymethyl)-8-oxo-2,4a,5a,6,7,8,8a,8b-octahydro-1H-pyrrolo[3',4':4,5]furo[3,2-b]pyridine-6-carboxylic acid × 1 SO4 SULFATE ION × 3 CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;20% PEG4000, 0.1M Lithium sulfate, 0.1M phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.30 Å R-free 0.258
4ISU Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (2R)-IKM-159 at 2.3A resolution. 提交 2013-01-17 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:Ligand-binding domain
链 B 653–796(144 aa) 片段:Ligand-binding domain
链 D 413–527(115 aa) 片段:Ligand-binding domain
链 D 653–796(144 aa) 片段:Ligand-binding domain
未记录 IKM (4aS,5aR,6R,8aS,8bS)-5a-(carboxymethyl)-8-oxo-2,4a,5a,6,7,8,8a,8b-octahydro-1H-pyrrolo[3',4':4,5]furo[3,2-b]pyridine-6-carboxylic acid × 1 SO4 SULFATE ION × 3 CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;20% PEG4000, 0.1M Lithium sulfate, 0.1M phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.30 Å R-free 0.258
4ISU Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (2R)-IKM-159 at 2.3A resolution. 提交 2013-01-17 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand-binding domain
链 A 653–796(144 aa) 片段:Ligand-binding domain
未记录 IKM (4aS,5aR,6R,8aS,8bS)-5a-(carboxymethyl)-8-oxo-2,4a,5a,6,7,8,8a,8b-octahydro-1H-pyrrolo[3',4':4,5]furo[3,2-b]pyridine-6-carboxylic acid × 1 SO4 SULFATE ION × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;20% PEG4000, 0.1M Lithium sulfate, 0.1M phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.30 Å R-free 0.258
4ISU Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (2R)-IKM-159 at 2.3A resolution. 提交 2013-01-17 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 413–527(115 aa) 片段:Ligand-binding domain
链 D 653–796(144 aa) 片段:Ligand-binding domain
未记录 SO4 SULFATE ION × 1 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;20% PEG4000, 0.1M Lithium sulfate, 0.1M phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.30 Å R-free 0.258
4ISU Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (2R)-IKM-159 at 2.3A resolution. 提交 2013-01-17 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 413–527(115 aa) 片段:Ligand-binding domain
链 C 653–796(144 aa) 片段:Ligand-binding domain
未记录 SO4 SULFATE ION × 2 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;20% PEG4000, 0.1M Lithium sulfate, 0.1M phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.30 Å R-free 0.258
4ISU Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (2R)-IKM-159 at 2.3A resolution. 提交 2013-01-17 Assembly 6 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:Ligand-binding domain
链 B 653–796(144 aa) 片段:Ligand-binding domain
未记录 IKM (4aS,5aR,6R,8aS,8bS)-5a-(carboxymethyl)-8-oxo-2,4a,5a,6,7,8,8a,8b-octahydro-1H-pyrrolo[3',4':4,5]furo[3,2-b]pyridine-6-carboxylic acid × 1 SO4 SULFATE ION × 2 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;20% PEG4000, 0.1M Lithium sulfate, 0.1M phosphate-citrate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 280K
分辨率 2.30 Å R-free 0.258
4IY5 Crystal structure of the glua2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and CX516 at 2.0 A resolution 提交 2013-01-28 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP RESIDUES 413-527, 653-796
链 A 653–796(144 aa) 片段:Ligand binding domain, UNP RESIDUES 413-527, 653-796
链 B 413–527(115 aa) 片段:Ligand binding domain, UNP RESIDUES 413-527, 653-796
链 B 653–796(144 aa) 片段:Ligand binding domain, UNP RESIDUES 413-527, 653-796
突变:L94Y, N242S 突变:L94Y, N242S 突变:L94Y, N242S 突变:L94Y, N242S GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 5 GOL GLYCEROL × 3 CL CHLORIDE ION × 3 CX5 piperidin-1-yl(quinoxalin-6-yl)methanone × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;24.4% PEG 4000, 0.3M lithium sulfate, 0.1M phosphate-citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 2.00 Å R-free 0.200
4IY6 Crystal structure of the GLUA2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and ME-CX516 at 1.72 A resolution 提交 2013-01-28 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, UNP RESIDUES 413-527, 653-796
链 A 653–796(144 aa) 片段:Ligand binding domain, UNP RESIDUES 413-527, 653-796
突变:L94Y, N242S 突变:L94Y, N242S MQR [(3R)-3-methylpiperidin-1-yl](quinoxalin-6-yl)methanone × 2 MQS [(3S)-3-methylpiperidin-1-yl](quinoxalin-6-yl)methanone × 4 GLU GLUTAMIC ACID × 2 GOL GLYCEROL × 2 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;15.2% PEG 4000, 0.3M lithium sulfate, 0.1M sodium acetate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.72 Å R-free 0.168
4L17 GluA2-L483Y-A665C ligand-binding domain in complex with the antagonist DNQX 提交 2013-06-02 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain (UNP residues 413-527, 653-796)
链 A 653–796(144 aa) 片段:Ligand binding domain (UNP residues 413-527, 653-796)
链 C 413–527(115 aa) 片段:Ligand binding domain (UNP residues 413-527, 653-796)
链 C 653–796(144 aa) 片段:Ligand binding domain (UNP residues 413-527, 653-796)
突变:L94Y, A153C 突变:L94Y, A153C 突变:L94Y, A153C 突变:L94Y, A153C DNQ 6,7-DINITROQUINOXALINE-2,3-DIONE × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;19% PEG 1450, 0.3M lithium sulfate, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K
分辨率 2.80 Å R-free 0.244
4L17 GluA2-L483Y-A665C ligand-binding domain in complex with the antagonist DNQX 提交 2013-06-02 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 E 413–527(115 aa) 片段:Ligand binding domain (UNP residues 413-527, 653-796)
链 E 653–796(144 aa) 片段:Ligand binding domain (UNP residues 413-527, 653-796)
突变:L94Y, A153C 突变:L94Y, A153C DNQ 6,7-DINITROQUINOXALINE-2,3-DIONE × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;19% PEG 1450, 0.3M lithium sulfate, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K
分辨率 2.80 Å R-free 0.244
4L17 GluA2-L483Y-A665C ligand-binding domain in complex with the antagonist DNQX 提交 2013-06-02 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 G 413–527(115 aa) 片段:Ligand binding domain (UNP residues 413-527, 653-796)
链 G 653–796(144 aa) 片段:Ligand binding domain (UNP residues 413-527, 653-796)
突变:L94Y, A153C 突变:L94Y, A153C DNQ 6,7-DINITROQUINOXALINE-2,3-DIONE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;19% PEG 1450, 0.3M lithium sulfate, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K
分辨率 2.80 Å R-free 0.244
4LZ5 Crystal structures of GLuR2 ligand-binding-domain in complex with glutamate and positive allosteric modulators 提交 2013-07-31 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 404–527(124 aa) 片段:SEE REMARK 999
链 A 653–796(144 aa) 片段:SEE REMARK 999
链 C 404–527(124 aa) 片段:SEE REMARK 999
链 C 653–796(144 aa) 片段:SEE REMARK 999
突变:G389R,L390G,E391A 突变:G389R,L390G,E391A 突变:G389R,L390G,E391A 突变:G389R,L390G,E391A GLU GLUTAMIC ACID × 2 ZN ZINC ION × 2 1YV N-[(2R)-2-(4'-cyanobiphenyl-4-yl)propyl]propane-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;1 uL 7 mg/mL protein in 10 mM (S)-Glu, 10 mM HEPES, pH 7.5, 20 mM sodium chloride, 1 mM EDTA, 150 uM ligand (from 30 mM DMSO stock) + 1 uL reservoir (10% PEG8000, 0.1 M zinc acetate, 0.1 M sodium acetate, pH 5.5), crystals appeared in 3-5 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.50 Å R-free 0.203
4LZ5 Crystal structures of GLuR2 ligand-binding-domain in complex with glutamate and positive allosteric modulators 提交 2013-07-31 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 404–527(124 aa) 片段:SEE REMARK 999
链 B 653–796(144 aa) 片段:SEE REMARK 999
突变:G389R,L390G,E391A 突变:G389R,L390G,E391A GLU GLUTAMIC ACID × 2 ZN ZINC ION × 6 1YV N-[(2R)-2-(4'-cyanobiphenyl-4-yl)propyl]propane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;1 uL 7 mg/mL protein in 10 mM (S)-Glu, 10 mM HEPES, pH 7.5, 20 mM sodium chloride, 1 mM EDTA, 150 uM ligand (from 30 mM DMSO stock) + 1 uL reservoir (10% PEG8000, 0.1 M zinc acetate, 0.1 M sodium acetate, pH 5.5), crystals appeared in 3-5 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.50 Å R-free 0.203
4LZ7 Crystal structures of GLuR2 ligand-binding-domain in complex with glutamate and positive allosteric modulators 提交 2013-07-31 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 404–527(124 aa) 片段:SEE REMARK 999
链 A 653–796(144 aa) 片段:SEE REMARK 999
链 C 404–527(124 aa) 片段:SEE REMARK 999
链 C 653–796(144 aa) 片段:SEE REMARK 999
突变:G389R,L390G,E391A 突变:G389R,L390G,E391A 突变:G389R,L390G,E391A 突变:G389R,L390G,E391A ZN ZINC ION × 3 GLU GLUTAMIC ACID × 2 1YW N-({(5S)-3-[3-fluoro-4-(pyrrolidin-1-yl)phenyl]-4,5-dihydro-1,2-oxazol-5-yl}methyl)acetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;1 uL 7 mg/mL protein in 10 mM (S)-Glu, 10 mM HEPES, pH 7.5, 20 mM sodium chloride, 1 mM EDTA, 150 uM ligand (from 30 mM DMSO stock) + 1 uL reservoir (10% PEG8000, 0.1 M zinc acetate, 0.1 M sodium acetate, pH 5.5), crystals appeared in 3-5 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.10 Å R-free 0.240
4LZ7 Crystal structures of GLuR2 ligand-binding-domain in complex with glutamate and positive allosteric modulators 提交 2013-07-31 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 404–527(124 aa) 片段:SEE REMARK 999
链 B 653–796(144 aa) 片段:SEE REMARK 999
突变:G389R,L390G,E391A 突变:G389R,L390G,E391A ZN ZINC ION × 4 GLU GLUTAMIC ACID × 2 1YW N-({(5S)-3-[3-fluoro-4-(pyrrolidin-1-yl)phenyl]-4,5-dihydro-1,2-oxazol-5-yl}methyl)acetamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;1 uL 7 mg/mL protein in 10 mM (S)-Glu, 10 mM HEPES, pH 7.5, 20 mM sodium chloride, 1 mM EDTA, 150 uM ligand (from 30 mM DMSO stock) + 1 uL reservoir (10% PEG8000, 0.1 M zinc acetate, 0.1 M sodium acetate, pH 5.5), crystals appeared in 3-5 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.10 Å R-free 0.240
4LZ8 Crystal structures of GLuR2 ligand-binding-domain in complex with glutamate and positive allosteric modulators 提交 2013-07-31 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 404–527(124 aa) 片段:SEE REMARK 999
链 A 653–796(144 aa) 片段:SEE REMARK 999
链 C 404–527(124 aa) 片段:SEE REMARK 999
链 C 653–796(144 aa) 片段:SEE REMARK 999
突变:G389R,L390G,E391A 突变:G389R,L390G,E391A 突变:G389R,L390G,E391A 突变:G389R,L390G,E391A GLU GLUTAMIC ACID × 2 1YX N-[(3S)-1-{2-fluoro-4-[(5S)-5-{[(propan-2-ylsulfonyl)amino]methyl}-4,5-dihydro-1,2-oxazol-3-yl]phenyl}pyrrolidin-3-yl]acetamide × 1 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;1 uL 7 mg/mL protein in 10 mM (S)-Glu, 10 mM HEPES, pH 7.5, 20 mM sodium chloride, 1 mM EDTA, 150 uM ligand (from 30 mM DMSO stock) + 1 uL reservoir (10% PEG8000, 0.1 M zinc acetate, 0.1 M sodium acetate, pH 5.5), crystals appeared in 3-5 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.85 Å R-free 0.232
4LZ8 Crystal structures of GLuR2 ligand-binding-domain in complex with glutamate and positive allosteric modulators 提交 2013-07-31 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 404–527(124 aa) 片段:SEE REMARK 999
链 B 653–796(144 aa) 片段:SEE REMARK 999
突变:G389R,L390G,E391A 突变:G389R,L390G,E391A GLU GLUTAMIC ACID × 2 1YX N-[(3S)-1-{2-fluoro-4-[(5S)-5-{[(propan-2-ylsulfonyl)amino]methyl}-4,5-dihydro-1,2-oxazol-3-yl]phenyl}pyrrolidin-3-yl]acetamide × 2 ZN ZINC ION × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;1 uL 7 mg/mL protein in 10 mM (S)-Glu, 10 mM HEPES, pH 7.5, 20 mM sodium chloride, 1 mM EDTA, 150 uM ligand (from 30 mM DMSO stock) + 1 uL reservoir (10% PEG8000, 0.1 M zinc acetate, 0.1 M sodium acetate, pH 5.5), crystals appeared in 3-5 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.85 Å R-free 0.232
4N07 Crystal structure of the GluA2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and BPAM-344 at 1.87 A resolution 提交 2013-10-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:unp residues 413-527, unp reisdues 653-796
链 A 653–796(144 aa) 片段:unp residues 413-527, unp reisdues 653-796
突变:L504Y, N755S 突变:L504Y, N755S 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 GLU GLUTAMIC ACID × 2 ACT ACETATE ION × 12 ZN ZINC ION × 8 CAC CACODYLATE ION × 2 GOL GLYCEROL × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16.5% PEG4000, 0.15 M zinc acetate, 0.1 M cacodylate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.87 Å R-free 0.211
4N07 Crystal structure of the GluA2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and BPAM-344 at 1.87 A resolution 提交 2013-10-01 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:unp residues 413-527, unp reisdues 653-796
链 B 653–796(144 aa) 片段:unp residues 413-527, unp reisdues 653-796
链 C 413–527(115 aa) 片段:unp residues 413-527, unp reisdues 653-796
链 C 653–796(144 aa) 片段:unp residues 413-527, unp reisdues 653-796
突变:L504Y, N755S 突变:L504Y, N755S 突变:L504Y, N755S 突变:L504Y, N755S 2J9 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 GLU GLUTAMIC ACID × 2 ACT ACETATE ION × 7 ZN ZINC ION × 6 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;16.5% PEG4000, 0.15 M zinc acetate, 0.1 M cacodylate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 1.87 Å R-free 0.211
4O3A Crystal structure of the glua2 ligand-binding domain in complex with L-aspartate at 1.80 a resolution 提交 2013-12-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
链 A 653–796(144 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
未记录 GOL GLYCEROL × 12 ASP ASPARTIC ACID × 2 ZN ZINC ION × 6 ACT ACETATE ION × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;24.4 % PEG 4000, 0.1 M zinc acetate and 0.1 M sodium acetate., pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.80 Å R-free 0.188
4O3A Crystal structure of the glua2 ligand-binding domain in complex with L-aspartate at 1.80 a resolution 提交 2013-12-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
链 B 653–796(144 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
未记录 GOL GLYCEROL × 4 ASP ASPARTIC ACID × 1 ZN ZINC ION × 2 ACT ACETATE ION × 1 PEG DI(HYDROXYETHYL)ETHER × 3 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;24.4 % PEG 4000, 0.1 M zinc acetate and 0.1 M sodium acetate., pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.80 Å R-free 0.188
4O3A Crystal structure of the glua2 ligand-binding domain in complex with L-aspartate at 1.80 a resolution 提交 2013-12-18 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 413–527(115 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
链 C 653–796(144 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
未记录 GOL GLYCEROL × 2 ASP ASPARTIC ACID × 1 ZN ZINC ION × 4 ACT ACETATE ION × 6 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;24.4 % PEG 4000, 0.1 M zinc acetate and 0.1 M sodium acetate., pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.80 Å R-free 0.188
4O3B Crystal structure of an open/closed glua2 ligand-binding domain dimer at 1.91 A resolution 提交 2013-12-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
链 A 653–796(144 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
链 B 413–527(115 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
链 B 653–796(144 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-736)
未记录 SO4 SULFATE ION × 4 GOL GLYCEROL × 6 CL CHLORIDE ION × 1 PEG DI(HYDROXYETHYL)ETHER × 1 ACT ACETATE ION × 1 GLU GLUTAMIC ACID × 1 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;20% PEG 4000, 0.1 M lithium sulfate and 0.1 M phosphate-citrate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.91 Å R-free 0.178
4O3C Crystal structure of the GLUA2 ligand-binding domain in complex with L-aspartate at 1.50 A resolution 提交 2013-12-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-796)
链 A 653–796(144 aa) 片段:Ligand binding domain (unp residues 413-527 and unp residues 653-796)
未记录 ASP ASPARTIC ACID × 2 CL CHLORIDE ION × 2 GOL GLYCEROL × 2 ACT ACETATE ION × 2 LI LITHIUM ION × 2 SO4 SULFATE ION × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;20% PEG 4000, 0.1 M lithium sulfate and 0.1 M phosphate-citrate., pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
分辨率 1.50 Å R-free 0.158
4Q30 Nitrowillardiine bound to the ligand binding domain of GluA2 at pH 3.5 提交 2014-04-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 414–527(114 aa)
链 B 653–794(142 aa)
链 D 414–527(114 aa)
链 D 653–794(142 aa)
未记录 NWD 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alanine × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 3.5;277 K;14-15% PEG 8K, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 3.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.03 Å R-free 0.230
4Q30 Nitrowillardiine bound to the ligand binding domain of GluA2 at pH 3.5 提交 2014-04-10 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 F 414–527(114 aa)
链 F 653–794(142 aa)
未记录 NWD 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alanine × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 3.5;277 K;14-15% PEG 8K, 0.1 M sodium cacodylate, 0.1-0.15 M zinc acetate, 0.25 M ammonium sulfate, pH 3.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
分辨率 2.03 Å R-free 0.230
4U1O GluA2flip sLBD complexed with kainate and (R,R)-2b crystal form C 提交 2014-07-15 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 1 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Na cacodylate, pH 6.5, 1.26 M ammonium sulfate
分辨率 1.85 Å R-free 0.209
4U1W Full length GluA2-kainate-(R,R)-2b complex crystal form A 提交 2014-07-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES, pH 6.5, 6%PEG6K, 3% TMAO, 0.006M Taurine
分辨率 3.25 Å R-free 0.316
4U1X Full length GluA2-kainate-(R,R)-2b complex crystal form B 提交 2014-07-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES, pH 6.2, 5.25% PEG6K, 3% TMAO, 0.006 M Taurine, 20 mM MnCl2
分辨率 3.30 Å R-free 0.289
4U1Y Full length GluA2-FW-(R,R)-2b complex 提交 2014-07-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 4 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M imidazole pH 6.2, 9% PEG1450, 3% TMAO
分辨率 3.90 Å R-free 0.303
4U1Z GluA2flip sLBD complexed with kainate and (R,R)-2b crystal form D 提交 2014-07-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 1 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Na acetate, pH 4.5, 25% PEG3350
分辨率 1.94 Å R-free 0.208
4U21 GluA2flip sLBD complexed with FW and (R,R)-2b crystal form E 提交 2014-07-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 654–796(143 aa)
链 B 413–527(115 aa)
链 B 654–796(143 aa)
突变:A796S 突变:A796S 突变:A796S 突变:A796S FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 2 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;phosphate-citrate, pH 4.2, 0.2 M Li sulfate, 20% PEG1K
分辨率 1.39 Å R-free 0.198
4U22 GluA2flip sLBD complexed with FW and (R,R)-2b crystal form D 提交 2014-07-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
突变:A796S 突变:A796S FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 1 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Na acetate, pH 4.5, 20% PEG3K
分辨率 1.44 Å R-free 0.217
4U23 GluA2flip sLBD complexed with FW and (R,R)-2b crystal form F 提交 2014-07-16 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
突变:A796S 突变:A796S FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 1 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M bicine/Trizma base, pH 8.5, 0.09 M Morpheus nitrate-phosphate-sulfate, 10% w/v PEG8K, 20% (v/v) ethylene glycol
分辨率 1.67 Å R-free 0.250
4U2P Full-length AMPA subtype ionotropic glutamate receptor GluA2 in the apo state 提交 2014-07-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277.15 K;0.1 M MES, 5.8-6.2% PEG6000, 5% TMAO, 0.1-0.3 M sodium acetate
分辨率 3.24 Å R-free 0.288
4U2Q Full-length AMPA subtype ionotropic glutamate receptor GluA2 in complex with partial agonist kainate 提交 2014-07-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277.15 K;0.1 M MES, 4.8-5.3% PEG6000, 3.5% TMAO, 6 mM taurine
分辨率 3.52 Å R-free 0.318
4U2R Crystal structure of the GLUR2 ligand binding core (S1S2J, flip variant) in the apo state 提交 2014-07-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
链 B 413–527(115 aa)
链 B 653–796(144 aa)
链 C 413–527(115 aa)
链 C 653–796(144 aa)
链 D 413–527(115 aa)
链 D 653–796(144 aa)
突变:A796S,A796S 突变:A796S,A796S 突变:A796S,A796S 突变:A796S,A796S 突变:A796S,A796S 突变:A796S,A796S 突变:A796S,A796S 突变:A796S,A796S SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;297 K;17-20% PEG8000, 0.2M lithium sulfate, 0.1 M sodium acetate
分辨率 1.41 Å R-free 0.232
4U2R Crystal structure of the GLUR2 ligand binding core (S1S2J, flip variant) in the apo state 提交 2014-07-17 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–796(144 aa)
突变:A796S,A796S 突变:A796S,A796S SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;297 K;17-20% PEG8000, 0.2M lithium sulfate, 0.1 M sodium acetate
分辨率 1.41 Å R-free 0.232
4U2R Crystal structure of the GLUR2 ligand binding core (S1S2J, flip variant) in the apo state 提交 2014-07-17 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
突变:A796S,A796S 突变:A796S,A796S 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;297 K;17-20% PEG8000, 0.2M lithium sulfate, 0.1 M sodium acetate
分辨率 1.41 Å R-free 0.232
4U2R Crystal structure of the GLUR2 ligand binding core (S1S2J, flip variant) in the apo state 提交 2014-07-17 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 413–527(115 aa)
链 C 653–796(144 aa)
突变:A796S,A796S 突变:A796S,A796S 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;297 K;17-20% PEG8000, 0.2M lithium sulfate, 0.1 M sodium acetate
分辨率 1.41 Å R-free 0.232
4U2R Crystal structure of the GLUR2 ligand binding core (S1S2J, flip variant) in the apo state 提交 2014-07-17 Assembly 5 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 413–527(115 aa)
链 D 653–796(144 aa)
突变:A796S,A796S 突变:A796S,A796S SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;297 K;17-20% PEG8000, 0.2M lithium sulfate, 0.1 M sodium acetate
分辨率 1.41 Å R-free 0.232
4U4F Structure of GluA2* in complex with partial agonist (S)-5-Nitrowillardiine 提交 2014-07-23 Assembly 1 其他组合 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 NWD 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alanine × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;11-14% (w/v) PEG 3,000, 50 mM lithium sulfate, 0.1 M tricine
分辨率 4.79 Å R-free 0.262
4U4G Structure of GluA2* in complex with competitive antagonist ZK 200775 提交 2014-07-23 Assembly 1 其他组合 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa) 片段:UNP residues 25-847
链 B 25–847(823 aa) 片段:UNP residues 25-847
链 C 25–847(823 aa) 片段:UNP residues 25-847
链 D 25–847(823 aa) 片段:UNP residues 25-847
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 X-RAY DIFFRACTION
X-ray结晶条件 BATCH MODE;277 K;7-11% PEG 20,000, 0.1 M MES
分辨率 4.49 Å R-free 0.248
4U4S Crystal structure of the GluA2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and BPAM25 at 1.90 A resolution. 提交 2014-07-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:Dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues 413-527, UNP residues 653-796
链 A 653–796(144 aa) 片段:UNP residues 413-527, UNP residues 653-796
链 B 413–527(115 aa) 片段:UNP residues 413-527, UNP residues 653-796
链 B 653–796(144 aa) 片段:UNP residues 413-527, UNP residues 653-796
突变:yes 突变:yes 突变:yes 突变:yes 3C1 4-ethyl-3,4-dihydro-2H-pyrido[4,3-e][1,2,4]thiadiazine 1,1-dioxide × 2 SO4 SULFATE ION × 3 GOL GLYCEROL × 4 ACT ACETATE ION × 8 CL CHLORIDE ION × 2 GLU GLUTAMIC ACID × 2 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;22% PEG4000, 0.2 M ammoniumsulfate, 0.1 M phosphate-citrate.
分辨率 1.90 Å R-free 0.208
4U4X Crystal structure of the GluA2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and BPAM37 at 1.56 A resolution. 提交 2014-07-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:Dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues 413-527, UNP residues 653-796
链 A 653–796(144 aa) 片段:UNP residues 413-527, UNP residues 653-796
链 B 413–527(115 aa) 片段:UNP residues 413-527, UNP residues 653-796
链 B 653–796(144 aa) 片段:UNP residues 413-527, UNP residues 653-796
突变:yes 突变:yes 突变:yes 突变:yes 3C2 4-ethyl-3,4-dihydro-2H-pyrido[3,2-e][1,2,4]thiadiazine 1,1-dioxide × 2 SO4 SULFATE ION × 5 GLU GLUTAMIC ACID × 2 ACT ACETATE ION × 4 GOL GLYCEROL × 3 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;24% PEG4000, 0.1 M ammoniumsulfate, 0.1 M phosphate-citrate
分辨率 1.56 Å R-free 0.175
4U5B Crystal structure of GluA2 A622T, con-ikot-ikot snail toxin, partial agonist KA and postitive modulator (R,R)-2b complex 提交 2014-07-25 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–845(821 aa)
链 B 25–845(821 aa)
链 C 25–845(821 aa)
链 D 25–845(821 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES pH 5.8-6.3, 0.1 M NaCl, 5%-6% PEG3350
分辨率 3.50 Å R-free 0.261
4U5C Crystal structure of GluA2, con-ikot-ikot snail toxin, partial agonist FW and postitive modulator (R,R)-2b complex 提交 2014-07-25 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–845(821 aa)
链 B 25–845(821 aa)
链 C 25–845(821 aa)
链 D 25–845(821 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 4 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES pH 5.8-6.3, 0.1 M NaCl, 5%-6% PEG3350
分辨率 3.69 Å R-free 0.254
4U5D Crystal structure of GluA2, con-ikot-ikot snail toxin, partial agonist KA and postitive modulator (R,R)-2b complex 提交 2014-07-25 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–845(821 aa)
链 B 25–845(821 aa)
链 C 25–845(821 aa)
链 D 25–845(821 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES pH 5.8-6.3, 0.1 M NaCl, 5%-6% PEG3350
分辨率 3.58 Å R-free 0.297
4U5E Crystal structure of GluA2 T625G, con-ikot-ikot snail toxin, partial agonist KA and postitive modulator (R,R)-2b complex 提交 2014-07-25 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–845(821 aa)
链 B 25–845(821 aa)
链 C 25–845(821 aa)
链 D 25–845(821 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES pH 5.8-6.3, 0.1 M NaCl, 5%-6% PEG3350
分辨率 3.51 Å R-free 0.276
4U5F Crystal structure of GluA2, con-ikot-ikot snail toxin, partial agonist KA and postitive modulator (R,R)-2b complex, GluA2cryst2 construct 提交 2014-07-24 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–848(824 aa)
链 B 25–848(824 aa)
链 C 25–848(824 aa)
链 D 25–848(824 aa)
未记录 KAI 3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;0.1 M MES pH 5.8-6.3, 0.1 M NaCl, 5%-6% PEG3350
分辨率 3.70 Å R-free 0.286
4UQ6 Electron density map of GluA2em in complex with LY451646 and glutamate 提交 2014-06-20 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 22–847(826 aa) 片段:RESIDUES 22-847
链 B 22–847(826 aa) 片段:RESIDUES 22-847
链 C 22–847(826 aa) 片段:RESIDUES 22-847
链 D 22–847(826 aa) 片段:RESIDUES 22-847
未记录 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;ETHANE
分辨率 12.80 Å
4UQJ Cryo-EM density map of GluA2em in complex with ZK200775 提交 2014-06-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 22–847(826 aa) 片段:RESIDUES 22-847
链 B 22–847(826 aa) 片段:RESIDUES 22-847
链 C 22–847(826 aa) 片段:RESIDUES 22-847
链 D 22–847(826 aa) 片段:RESIDUES 22-847
突变:YES 突变:YES 突变:YES 突变:YES ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 150 MM NACL, 20 MM TRIS, 0.75 MM DDM, 0.12 MM CHS, 0.3 MM ZK200775;pH 8;150 MM NACL, 20 MM TRIS, 0.75 MM DDM, 0.12 MM CHS, 0.3 MM ZK200775
cryo-EM玻璃化条件 冷冻剂 ETHANE;ETHANE
分辨率 10.40 Å
4UQK Electron density map of GluA2em in complex with quisqualate and LY451646 提交 2014-06-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 22–847(826 aa) 片段:RESIDUES 22-847
链 B 22–847(826 aa) 片段:RESIDUES 22-847
链 C 22–847(826 aa) 片段:RESIDUES 22-847
链 D 22–847(826 aa) 片段:RESIDUES 22-847
未记录 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;ETHANE
分辨率 16.40 Å
4X48 Crystal structure of GluR2 ligand-binding core 提交 2014-12-02 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:Ligand binding domain, engineered single chain
链 A 653–796(144 aa) 片段:Ligand binding domain, engineered single chain
链 C 413–527(115 aa) 片段:Ligand binding domain, engineered single chain
链 C 653–796(144 aa) 片段:Ligand binding domain, engineered single chain
未记录 GLU GLUTAMIC ACID × 2 ZN ZINC ION × 3 XPF N-{(3S,4S)-4-[4-(5-cyanothiophen-2-yl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;The protein solution contained 7 mg/ml GluR2-S1S2J, 10mM (S)-Glu, 10mM HEPES (pH 7.5), 20mM NaCl and 1mM EDTA. Compound was added to a final concentration of 150micromolar from a 30mM DMSO stock. To this solution, an equal amount of reservoir solution containing 10% PEG 8000, 0.1 M ZnAc and 0.1M NaAc, pH 5.5 was added, and 2microlitre drops of this mixture were allowed to equilibrate by vapor diffusion over a 1mL reservoir. Crystals appeared in the drops in 3-5 days.
分辨率 1.89 Å R-free 0.197
4X48 Crystal structure of GluR2 ligand-binding core 提交 2014-12-02 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:Ligand binding domain, engineered single chain
链 B 653–796(144 aa) 片段:Ligand binding domain, engineered single chain
未记录 GLU GLUTAMIC ACID × 2 ZN ZINC ION × 4 XPF N-{(3S,4S)-4-[4-(5-cyanothiophen-2-yl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;The protein solution contained 7 mg/ml GluR2-S1S2J, 10mM (S)-Glu, 10mM HEPES (pH 7.5), 20mM NaCl and 1mM EDTA. Compound was added to a final concentration of 150micromolar from a 30mM DMSO stock. To this solution, an equal amount of reservoir solution containing 10% PEG 8000, 0.1 M ZnAc and 0.1M NaAc, pH 5.5 was added, and 2microlitre drops of this mixture were allowed to equilibrate by vapor diffusion over a 1mL reservoir. Crystals appeared in the drops in 3-5 days.
分辨率 1.89 Å R-free 0.197
4YMA Structure of the ligand-binding domain of GluA2 in complex with the antagonist CNG10109 提交 2015-03-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 SO4 SULFATE ION × 6 GOL GLYCEROL × 2 4E5 (3R)-3-(3-carboxy-5-hydroxyphenyl)-L-proline × 2 EDO 1,2-ETHANEDIOL × 2 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;PEG4000, lithium sulfate, phosphate citrate
分辨率 1.90 Å R-free 0.228
4YU0 Crystal structure of a tetramer of GluA2 TR mutant ligand binding domains bound with glutamate at 1.26 Angstrom resolution 提交 2015-03-18 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
突变:E713T, Y768R,E713T, Y768R 突变:E713T, Y768R,E713T, Y768R GLU GLUTAMIC ACID × 1 PO4 PHOSPHATE ION × 3 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;277.14 K;20% w/v PEG3350 and 200 mM (NH4)2HPO4
分辨率 1.26 Å R-free 0.157
4YU0 Crystal structure of a tetramer of GluA2 TR mutant ligand binding domains bound with glutamate at 1.26 Angstrom resolution 提交 2015-03-18 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–796(144 aa)
突变:E713T, Y768R,E713T, Y768R 突变:E713T, Y768R,E713T, Y768R GLU GLUTAMIC ACID × 1 PO4 PHOSPHATE ION × 3 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;277.14 K;20% w/v PEG3350 and 200 mM (NH4)2HPO4
分辨率 1.26 Å R-free 0.157
4Z0I Crystal structure of a tetramer of GluA2 ligand binding domains bound with glutamate at 1.45 Angstrom resolution 提交 2015-03-26 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–796(144 aa)
未记录 GLU GLUTAMIC ACID × 2 PO4 PHOSPHATE ION × 6 PG4 TETRAETHYLENE GLYCOL × 2 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;277.14 K;20% PEG 3350 and 200 mM KNO3
分辨率 1.45 Å R-free 0.208
4Z0I Crystal structure of a tetramer of GluA2 ligand binding domains bound with glutamate at 1.45 Angstrom resolution 提交 2015-03-26 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–796(144 aa)
未记录 GLU GLUTAMIC ACID × 2 PO4 PHOSPHATE ION × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;277.14 K;20% PEG 3350 and 200 mM KNO3
分辨率 1.45 Å R-free 0.208
5BUU Crystal structure of the GluA2 ligand-binding domain (L483Y-N754S) in complex with glutamate and BPAM-321 at 2.07 A resolution 提交 2015-06-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues 413-527,UNP residues 653-796
链 A 653–796(144 aa) 片段:UNP residues 413-527,UNP residues 653-796
链 B 413–527(115 aa) 片段:UNP residues 413-527,UNP residues 653-796
链 B 653–796(144 aa) 片段:UNP residues 413-527,UNP residues 653-796
突变:L483Y, N754S,L483Y, N754S 突变:L483Y, N754S,L483Y, N754S 突变:L483Y, N754S,L483Y, N754S 突变:L483Y, N754S,L483Y, N754S 4V6 (3R)-7-chloro-2,3,4-trimethyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 5 EDO 1,2-ETHANEDIOL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;15.2 % PEG4000, 0.2 M ammonium-sulfate, 0.1 M phosphate-citrate
分辨率 2.07 Å R-free 0.250
5CBR Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (S)-2-amino-3-(3,4-dichloro-5-(5-hydroxypyridin-3-yl)phenyl)propanoic acid at 2.0A resolution 提交 2015-07-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 4ZK 3,4-dichloro-5-(5-hydroxypyridin-3-yl)-L-phenylalanine × 2 GOL GLYCEROL × 6 SO4 SULFATE ION × 12 ACT ACETATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;PEG4000, lithium sulfate and phosphate-citrate buffer pH 4.5
分辨率 2.00 Å R-free 0.238
5CBS Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (R)-2-amino-3-(3'-hydroxybiphenyl-3-yl)propanoic acid at 1.8A resolution 提交 2015-07-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues 413-527,UNP residues 653-797
链 A 653–797(145 aa) 片段:UNP residues 413-527,UNP residues 653-797
链 C 413–527(115 aa) 片段:UNP residues 413-527,UNP residues 653-797
链 C 653–797(145 aa) 片段:UNP residues 413-527,UNP residues 653-797
未记录 E42 (R)-2-amino-3-(3'-hydroxybiphenyl-3-yl)propanoic acid × 2 SO4 SULFATE ION × 5 EDO 1,2-ETHANEDIOL × 4 GOL GLYCEROL × 3 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;PEG2000, lithium sulfate and phosphate-citrate buffer pH 4.5
分辨率 1.80 Å R-free 0.219
5CBS Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the antagonist (R)-2-amino-3-(3'-hydroxybiphenyl-3-yl)propanoic acid at 1.8A resolution 提交 2015-07-01 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa) 片段:UNP residues 413-527,UNP residues 653-797
链 B 653–797(145 aa) 片段:UNP residues 413-527,UNP residues 653-797
链 D 413–527(115 aa) 片段:UNP residues 413-527,UNP residues 653-797
链 D 653–797(145 aa) 片段:UNP residues 413-527,UNP residues 653-797
未记录 E42 (R)-2-amino-3-(3'-hydroxybiphenyl-3-yl)propanoic acid × 2 SO4 SULFATE ION × 5 EDO 1,2-ETHANEDIOL × 10 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;PEG2000, lithium sulfate and phosphate-citrate buffer pH 4.5
分辨率 1.80 Å R-free 0.219
5ELV Crystal structure of the GluA2 ligand-binding domain (S1S2J-L504-N775) in complex with glutamate and BPAM-521 at 1.92 A resolution 提交 2015-11-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa) 片段:UNP residues, 413-527,UNP residue, 653-797
链 A 653–797(145 aa) 片段:UNP residues, 413-527,UNP residue, 653-797
链 B 413–527(115 aa) 片段:UNP residues, 413-527,UNP residue, 653-797
链 B 653–797(145 aa) 片段:UNP residues, 413-527,UNP residue, 653-797
突变:L504Y and N775S 突变:L504Y and N775S 突变:L504Y and N775S 突变:L504Y and N775S SO4 SULFATE ION × 4 GOL GLYCEROL × 4 CL CHLORIDE ION × 3 ACT ACETATE ION × 9 5PX 4-Cyclopropyl-3,4-dihydro-7-hydroxy-2H-1,2,4-benzothiadiazine 1,1-dioxide × 2 GLU GLUTAMIC ACID × 2 PEG DI(HYDROXYETHYL)ETHER × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;20% PEG4000, 0.3 M lithium sulfate and 0.1 M phosphate-citrate
分辨率 1.92 Å R-free 0.209
5FHM Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with (S)-2-Amino-3-(5-(2-(3-(aminomethyl)benzyl)-2H-tetrazol-5-yl)-3-hydroxyisoxazol-4-yl)propanoic acid at resolution 1.55 A resolution 提交 2015-12-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 SO4 SULFATE ION × 6 5XP (2~{S})-3-[5-[2-[[3-(aminomethyl)phenyl]methyl]-1,2,3,4-tetrazol-5-yl]-3-oxidanyl-1,2-oxazol-4-yl]-2-azanyl-propanoic acid × 1 GOL GLYCEROL × 2 ACT ACETATE ION × 4 EDO 1,2-ETHANEDIOL × 7 LI LITHIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;280 K;PEG4000 lithium sulfate sodium acetate buffer pH 5.5
分辨率 1.55 Å R-free 0.159
5FHN Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with (S)-2-Amino-3-(5-(2-(3-methylbenzyl)-2H-tetrazol-5-yl)-3-hydroxyisoxazol-4-yl)propanoic acid at 1.6 A resolution 提交 2015-12-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 SO4 SULFATE ION × 1 GOL GLYCEROL × 2 ACT ACETATE ION × 1 5XO (S)-2-Amino-3-(5-(2-(3-methylbenzyl)-2H-tetrazol-5-yl)-3-hydroxyisoxazol-4-yl)propanoic acid × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;18% PEG4000 0.1 M ammonium sulfate 0.1 M phosphate-citrate buffer pH 4.5
分辨率 1.60 Å R-free 0.186
5FHO Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with (S)-2-Amino-3-(5-(2-(3-chlorobenzyl)-2H-tetrazol-5-yl)-3-hydroxyisoxazol-4-yl)propanoic acid at 2.3 A resolution 提交 2015-12-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 D 413–527(115 aa)
链 D 653–797(145 aa)
未记录 5XN (1S)-1-carboxy-2-(5-{2-[(3-chlorophenyl)methyl]-2H-tetrazol-5-yl}-3-oxo-2,3-dihydro-1,2-oxazol-4-yl)ethan-1-aminium × 2 SO4 SULFATE ION × 6 GOL GLYCEROL × 2 CL CHLORIDE ION × 5 EDO 1,2-ETHANEDIOL × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;280 K;PEG4000 ammonium sulfate acetate buffer pH 5.5
分辨率 2.30 Å R-free 0.216
5FHO Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with (S)-2-Amino-3-(5-(2-(3-chlorobenzyl)-2H-tetrazol-5-yl)-3-hydroxyisoxazol-4-yl)propanoic acid at 2.3 A resolution 提交 2015-12-22 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–797(145 aa)
链 C 413–527(115 aa)
链 C 653–797(145 aa)
未记录 5XN (1S)-1-carboxy-2-(5-{2-[(3-chlorophenyl)methyl]-2H-tetrazol-5-yl}-3-oxo-2,3-dihydro-1,2-oxazol-4-yl)ethan-1-aminium × 2 SO4 SULFATE ION × 6 GOL GLYCEROL × 4 CL CHLORIDE ION × 4 EDO 1,2-ETHANEDIOL × 6 PG4 TETRAETHYLENE GLYCOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;280 K;PEG4000 ammonium sulfate acetate buffer pH 5.5
分辨率 2.30 Å R-free 0.216
5FTH Crystal structure of the GluA2 K738M-T744K LBD in complex with glutamate (zinc form) 提交 2016-01-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 404–527(124 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
链 A 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
链 B 404–527(124 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
链 B 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
突变:YES 突变:YES 突变:YES 突变:YES GLU GLUTAMIC ACID × 2 ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 pH 6;15% PEG 8,000, 200 MM ZN ACETATE, 100MM MES PH 6.0
分辨率 2.90 Å R-free 0.283
5FTH Crystal structure of the GluA2 K738M-T744K LBD in complex with glutamate (zinc form) 提交 2016-01-13 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 404–527(124 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
链 C 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
突变:YES 突变:YES GLU GLUTAMIC ACID × 2 ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6;15% PEG 8,000, 200 MM ZN ACETATE, 100MM MES PH 6.0
分辨率 2.90 Å R-free 0.283
5FTI Crystal structure of the GluA2 K738M-T744K LBD in complex with glutamate (lithium form) 提交 2016-01-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 404–527(124 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
链 A 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
突变:YES 突变:YES GLU GLUTAMIC ACID × 2 LI LITHIUM ION × 2 SO4 SULFATE ION × 4 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 5;22% PEG 4,000, 200 MM LI SULPHATE, 100MM ACETATE PH 5.0
分辨率 1.35 Å R-free 0.177
5FTI Crystal structure of the GluA2 K738M-T744K LBD in complex with glutamate (lithium form) 提交 2016-01-13 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 404–527(124 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
链 B 653–796(144 aa) 片段:LIGAND BINDING DOMAIN, UNP RESIDUES 404-527,653-796
突变:YES 突变:YES GLU GLUTAMIC ACID × 2 LI LITHIUM ION × 2 SO4 SULFATE ION × 4 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 5;22% PEG 4,000, 200 MM LI SULPHATE, 100MM ACETATE PH 5.0
分辨率 1.35 Å R-free 0.177
5FWX Crystal structure of the AMPA receptor GluA2/A4 N-terminal domain heterodimer 提交 2016-02-21 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 25–400(376 aa) 片段:RESIDUES 25-400
未记录 SO4 SULFATE ION × 2 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray结晶条件 17% PEG 3350 WITH 0.1-0.35 M AMMONIUM SULPHATE
分辨率 2.50 Å R-free 0.238
5FWX Crystal structure of the AMPA receptor GluA2/A4 N-terminal domain heterodimer 提交 2016-02-21 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 25–400(376 aa) 片段:RESIDUES 25-400
未记录 SO4 SULFATE ION × 2 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray结晶条件 17% PEG 3350 WITH 0.1-0.35 M AMMONIUM SULPHATE
分辨率 2.50 Å R-free 0.238
5FWY Crystal structure of the AMPA receptor GluA2/A3 N-terminal domain heterodimer 提交 2016-02-21 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 25–400(376 aa) 片段:RESIDUES 25-400
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 SO4 SULFATE ION × 5 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 14-16 % PEG 3350, 0.27 M AMMONIUM SULPHATE AND 0.1 M BICINE PH 9
分辨率 2.12 Å R-free 0.231
5FWY Crystal structure of the AMPA receptor GluA2/A3 N-terminal domain heterodimer 提交 2016-02-21 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 25–400(376 aa) 片段:RESIDUES 25-400
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray结晶条件 14-16 % PEG 3350, 0.27 M AMMONIUM SULPHATE AND 0.1 M BICINE PH 9
分辨率 2.12 Å R-free 0.231
5IDE Cryo-EM structure of GluA2/3 AMPA receptor heterotetramer (model I) 提交 2016-02-24 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 23–883(861 aa)
链 C 23–883(861 aa)
突变:N292C 突变:N292C 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;25 mM Tris pH 7.4, 0.25 % DDM, 150 mM NaCl
cryo-EM玻璃化条件 冷冻剂 ETHANE;Incubated for 1 minute, blotted for 3 seconds
分辨率 8.25 Å
5IDF Cryo-EM structure of GluA2/3 AMPA receptor heterotetramer (model II) 提交 2016-02-24 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 23–883(861 aa)
链 C 23–883(861 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 7.4;25 mM Tris pH 7.4, 0.25 % DDM, 150 mM NaCl
cryo-EM玻璃化条件 冷冻剂 ETHANE;Incubated for 1 minute, blotted for 3 seconds
分辨率 10.31 Å
5JEI Crystal structure of the GluA2 LBD in complex with FW 提交 2016-04-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
突变:V154C,V154C 突变:V154C,V154C FWD 2-AMINO-3-(5-FLUORO-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YL)-PROPIONIC ACID × 4 PO4 PHOSPHATE ION × 8 PG4 TETRAETHYLENE GLYCOL × 8 PEG DI(HYDROXYETHYL)ETHER × 12 TOE 2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL × 4 PG0 2-(2-METHOXYETHOXY)ETHANOL × 4 ETE 2-{2-[2-2-(METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 8 EDO 1,2-ETHANEDIOL × 4 NA SODIUM ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.2;277 K;50.0 % v/v PEG 200, 200 mM Sodium Chloride, 100 mM Sodium/Potassium Phosphate pH 6.2
分辨率 1.23 Å R-free 0.147
5KBS Cryo-EM structure of GluA2-0xSTZ at 8.7 Angstrom resolution 提交 2016-06-03 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
突变:N241E, V382L, G384E, N385D, V758L,N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L,N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L,N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L,N241E, V382L, G384E, N385D, V758L ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;3 blot force, 8.0 s blot time
分辨率 8.70 Å
5KBT Cryo-EM structure of GluA2-1xSTZ complex at 6.4 Angstrom resolution 提交 2016-06-03 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;3 blot force, 8.0 s blot time
分辨率 6.40 Å
5KBU Cryo-EM structure of GluA2-2xSTZ complex at 7.8 Angstrom resolution 提交 2016-06-03 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;3 blot force, 8.0 s blot time
分辨率 7.80 Å
5KBV Cryo-EM structure of GluA2 bound to antagonist ZK200775 at 6.8 Angstrom resolution 提交 2016-06-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
突变:N241E, V382L,G384E, N385D, V758L 突变:N241E, V382L,G384E, N385D, V758L 突变:N241E, V382L,G384E, N385D, V758L 突变:N241E, V382L,G384E, N385D, V758L ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;Blot force 3, 8.0 s blot time
分辨率 6.80 Å
5KK2 Architecture of fully occupied GluA2 AMPA receptor - TARP complex elucidated by single particle cryo-electron microscopy 提交 2016-06-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 7.30 Å
5L1B AMPA subtype ionotropic glutamate receptor GluA2 in Apo state 提交 2016-07-28 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587,UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 A 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587,UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587,UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587,UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587,UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587,UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587,UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587,UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;8-11% (w/v) PEG 8,000, 0.2 M magnesium acetate and 0.1 M sodium cacodylate (pH 6.3-6.7)
分辨率 4.00 Å R-free 0.292
5L1E AMPA subtype ionotropic glutamate receptor GluA2 in complex with noncompetitive inhibitor CP465022 提交 2016-07-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 A 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 6ZQ 3-(2-chlorophenyl)-2-(2-{6-[(diethylamino)methyl]pyridin-2-yl}ethyl)-6-fluoroquinazolin-4(3H)-one × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;11-14% (w/v) PEG 6,000, 0.1 M ammonium phosphate and 0.1 M TRIS (pH 7.9-8.0)
分辨率 4.37 Å R-free 0.292
5L1F AMPA subtype ionotropic glutamate receptor GluA2 in complex with noncompetitive inhibitor Perampanel 提交 2016-07-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 A 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 6ZP 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;11-14% (w/v) PEG 6,000, 0.1 M ammonium phosphate and 0.1 M TRIS (pH 7.9-8.0)
分辨率 4.00 Å R-free 0.272
5L1G AMPA subtype ionotropic glutamate receptor GluA2 in complex with GYKI-Br 提交 2016-07-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 A 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 GYB (8R)-5-(4-amino-3-bromophenyl)-N,8-dimethyl-8,9-dihydro-2H,7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;sodium acetate
分辨率 4.51 Å R-free 0.295
5L1H AMPA subtype ionotropic glutamate receptor GluA2 in complex with noncompetitive inhibitor GYKI53655 提交 2016-07-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 A 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 B 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 C 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 25–565(541 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
链 D 588–847(260 aa) 片段:UNP residues 25-847, with deletions of 397-398, 402-405, 566-587
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 GYK (8R)-5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-2H,7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;277 K;11-14% (w/v) PEG 6,000, 0.1 M ammonium phosphate and 0.1 M TRIS (pH 7.9-8.0)
分辨率 3.80 Å R-free 0.292
5N6P AMPA receptor NTD mutant 提交 2017-02-15 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 25–400(376 aa)
突变:K73C D134C NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.6;291 K;16-20% PEG3350, 200 mM sodium formate
分辨率 2.80 Å R-free 0.249
5NG9 Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with agonist CIP-AS at 1.15 A resolution. 提交 2017-03-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 FLC CITRATE ANION × 4 LI LITHIUM ION × 2 8VN (3~{a}~{S},4~{S},6~{a}~{R})-4,5,6,6~{a}-tetrahydro-3~{a}~{H}-pyrrolo[3,4-d][1,2]oxazole-3,4-dicarboxylic acid × 2 8WQ (2~{S},3~{R},4~{R})-3-(carboxycarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylic acid × 2 SO4 SULFATE ION × 6 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;15.2% PEG4000, 0.1 M lithium sulfate, 0.1 M phosphate-citrate buffer
分辨率 1.15 Å R-free 0.133
5NIH Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with agonist LM-12b at 1.3 A resolution. 提交 2017-03-24 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 SO4 SULFATE ION × 3 8VE (3~{a}~{R},4~{S},6~{a}~{R})-1-methyl-4,5,6,6~{a}-tetrahydro-3~{a}~{H}-pyrrolo[3,4-c]pyrazole-3,4-dicarboxylic acid × 1 GOL GLYCEROL × 3 CL CHLORIDE ION × 1 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;24.4% PEG4000, 0.3 M ammonium sulfate, 0.1 M phosphate-citrate buffer
分辨率 1.30 Å R-free 0.158
5NIH Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with agonist LM-12b at 1.3 A resolution. 提交 2017-03-24 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 SO4 SULFATE ION × 2 8VE (3~{a}~{R},4~{S},6~{a}~{R})-1-methyl-4,5,6,6~{a}-tetrahydro-3~{a}~{H}-pyrrolo[3,4-c]pyrazole-3,4-dicarboxylic acid × 1 GOL GLYCEROL × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;24.4% PEG4000, 0.3 M ammonium sulfate, 0.1 M phosphate-citrate buffer
分辨率 1.30 Å R-free 0.158
5NS9 Crystal structure of the GluA2 LBD (L483Y-N754S-L758V) in complex with glutamate 提交 2017-04-25 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 1PE PENTAETHYLENE GLYCOL × 2 PG0 2-(2-METHOXYETHOXY)ETHANOL × 1 SO4 SULFATE ION × 6 NA SODIUM ION × 5 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;277.15 K;20% w/v PEG3350, 200mM Li2SO4
分辨率 1.44 Å R-free 0.205
5O9A Crystal structure of the GluA2 ligand-binding domain (S1S2J-L504Y-N775S) in complex with glutamate and BPAM121 at 1.78 A resolution 提交 2017-06-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
突变:L504Y,N775S 突变:L504Y,N775S 突变:L504Y,N775S 突变:L504Y,N775S SO4 SULFATE ION × 6 7M6 7-chloro-4-(2-fluoroethyl)-2,3-dihydro-1,2,4-benzothiadiazine 1,1-dioxide × 2 CL CHLORIDE ION × 4 GOL GLYCEROL × 3 GLU GLUTAMIC ACID × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;18% PEG4000, 0.23 M lithium sulfate, 0.1 M phosphate citrate pH 4.5
分辨率 1.78 Å R-free 0.179
5O9A Crystal structure of the GluA2 ligand-binding domain (S1S2J-L504Y-N775S) in complex with glutamate and BPAM121 at 1.78 A resolution 提交 2017-06-16 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa)
链 C 653–797(145 aa)
链 D 413–527(115 aa)
链 D 653–797(145 aa)
突变:L504Y,N775S 突变:L504Y,N775S 突变:L504Y,N775S 突变:L504Y,N775S SO4 SULFATE ION × 10 7M6 7-chloro-4-(2-fluoroethyl)-2,3-dihydro-1,2,4-benzothiadiazine 1,1-dioxide × 2 CL CHLORIDE ION × 3 GOL GLYCEROL × 1 GLU GLUTAMIC ACID × 2 CIT CITRIC ACID × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;18% PEG4000, 0.23 M lithium sulfate, 0.1 M phosphate citrate pH 4.5
分辨率 1.78 Å R-free 0.179
5OEW Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with glutamate and positive allosteric modulator BPAM538 提交 2017-07-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 GLU GLUTAMIC ACID × 2 ZN ZINC ION × 9 ACT ACETATE ION × 2 9TE 4-cyclopropyl-7-(3-methoxyphenoxy)-2,3-dihydro-1$l^{6},2,4-benzothiadiazine 1,1-dioxide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;18% PEG4000, 0.23M lithium-sulfate, 0.1M phosphate-citrate
分辨率 2.00 Å R-free 0.189
5OEW Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with glutamate and positive allosteric modulator BPAM538 提交 2017-07-10 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa)
链 C 653–797(145 aa)
未记录 GLU GLUTAMIC ACID × 2 ZN ZINC ION × 16 ACT ACETATE ION × 4 9TE 4-cyclopropyl-7-(3-methoxyphenoxy)-2,3-dihydro-1$l^{6},2,4-benzothiadiazine 1,1-dioxide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;18% PEG4000, 0.23M lithium-sulfate, 0.1M phosphate-citrate
分辨率 2.00 Å R-free 0.189
5VHW GluA2-0xGSG1L bound to ZK 提交 2017-04-13 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 7.80 Å
5VHX GluA2-1xGSG1L bound to ZK 提交 2017-04-13 Assembly 1 信息不足 同源多聚体;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
链 E 25–847(823 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 8.30 Å
5VHY GluA2-2xGSG1L bound to ZK 提交 2017-04-13 Assembly 1 信息不足 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
链 E 25–847(823 aa)
链 F 25–847(823 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.60 Å
5VHZ GluA2-2xGSG1L bound to L-Quisqualate 提交 2017-04-13 Assembly 1 信息不足 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
链 E 25–847(823 aa)
链 F 25–847(823 aa)
未记录 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 8.40 Å
5VOT Structure of AMPA receptor-TARP complex 提交 2017-05-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.90 Å
5VOU Structure of AMPA receptor-TARP complex 提交 2017-05-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 6.40 Å
5VOV Structure of AMPA receptor-TARP complex 提交 2017-05-03 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 7.70 Å
5WEK GluA2 bound to antagonist ZK and GSG1L in digitonin, state 1 提交 2017-07-10 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 B 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 C 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 D 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP D3Z7H4 residues 2-238 linked via LINKER GTG
突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.60 Å
5WEL GluA2 bound to antagonist ZK and GSG1L in digitonin, state 2 提交 2017-07-10 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 B 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 C 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 D 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP D3Z7H4 residues 2-238 linked via LINKER GTG
突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 AJP Digitonin × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.40 Å
5WEM GluA2 bound to GSG1L in digitonin, state 1 提交 2017-07-10 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa) 片段:UNP P19491 residues 25-847 and UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 B 25–847(823 aa) 片段:UNP P19491 residues 25-847 and UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 C 25–847(823 aa) 片段:UNP P19491 residues 25-847 and UNP D3Z7H4 residues 2-238 linked via LINKER GTG
链 D 25–847(823 aa) 片段:UNP P19491 residues 25-847 and UNP D3Z7H4 residues 2-238 linked via LINKER GTG
突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 6.10 Å
5WEN GluA2 bound to GSG1L in digitonin, state 2 提交 2017-07-10 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa) 片段:UNP residues 25-847 and UNP residues 2-238 linked via LINKER GTG,UNP residues 25-847 and UNP residues 2-238 linked via LINKER GTG
链 B 25–847(823 aa) 片段:UNP residues 25-847 and UNP residues 2-238 linked via LINKER GTG,UNP residues 25-847 and UNP residues 2-238 linked via LINKER GTG
链 C 25–847(823 aa) 片段:UNP residues 25-847 and UNP residues 2-238 linked via LINKER GTG,UNP residues 25-847 and UNP residues 2-238 linked via LINKER GTG
链 D 25–847(823 aa) 片段:UNP residues 25-847 and UNP residues 2-238 linked via LINKER GTG,UNP residues 25-847 and UNP residues 2-238 linked via LINKER GTG
突变:N241E, V382L, G384E, N385D, N392Q, V1151L,N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L,N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L,N241E, V382L, G384E, N385D, N392Q, V1151L 突变:N241E, V382L, G384E, N385D, N392Q, V1151L,N241E, V382L, G384E, N385D, N392Q, V1151L AJP Digitonin × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 6.80 Å
5WEO Activated GluA2 complex bound to glutamate, cyclothiazide, and STZ in digitonin 提交 2017-07-10 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP O88602 2-208 linked via LINKER GT
链 B 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP O88602 2-208 linked via LINKER GT
链 C 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP O88602 2-208 linked via LINKER GT
链 D 25–847(823 aa) 片段:UNP P19491 residues 25-847, UNP O88602 2-208 linked via LINKER GT
突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L 突变:N241E, V382L, G384E, N385D, V758L GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.20 Å
6DLZ Open state GluA2 in complex with STZ after micelle signal subtraction 提交 2018-06-04 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.90 Å
6DM0 Open state GluA2 in complex with STZ and blocked by IEM-1460, after micelle signal subtraction 提交 2018-06-04 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 GZD N,N,N-trimethyl-5-({[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]decan-1-yl]methyl}amino)pentan-1-aminium × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.40 Å
6DM1 Open state GluA2 in complex with STZ and blocked by NASPM, after micelle signal subtraction 提交 2018-06-04 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 GYY N-[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl]-2-(naphthalen-1-yl)acetamide × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.20 Å
6FAZ Crystal structure of the GluA2 ligand-binding domain (S1S2J) in complex with the positive allosteric modulator TDPAM01 at 1.4 A resolution. 提交 2017-12-18 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 SO4 SULFATE ION × 5 PEG DI(HYDROXYETHYL)ETHER × 2 GOL GLYCEROL × 5 CL CHLORIDE ION × 5 ACT ACETATE ION × 3 GLU GLUTAMIC ACID × 2 EDO 1,2-ETHANEDIOL × 2 D45 6,6'-(Ethane-1,2-diyl)bis(4-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide) × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;280 K;15% PEG4000, 0.3 M ammonium sulfate, 0.1 M phosphate-citrate
分辨率 1.40 Å R-free 0.168
6FQG GluA2(flop) G724C ligand binding core dimer bound to L-Glutamate (Form A) at 2.34 Angstrom resolution 提交 2018-02-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
突变:S729C 突变:S729C 突变:S729C 突变:S729C GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4;287 K;0.2M Ammonium chloride, 20% PEG 3350, 10uM ZK200775
分辨率 2.34 Å R-free 0.231
6FQH GluA2(flop) S729C ligand binding core dimer bound to NBQX at 1.76 Angstrom resolution 提交 2018-02-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 400–527(128 aa)
链 A 653–797(145 aa)
链 B 400–527(128 aa)
链 B 653–797(145 aa)
突变:S729C,S729C 突变:S729C,S729C 突变:S729C,S729C 突变:S729C,S729C E2Q 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;289 K;0.1M tri-sodium Citrate, 20% PEG 3000
分辨率 1.76 Å R-free 0.224
6FQI GluA2(flop) G724C ligand binding core dimer bound to L-Glutamate (Form B) at 2.91 Angstrom resolution 提交 2018-02-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 GLU GLUTAMIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.5;289 K;0.16 M Calcium acetate, 0.08 M Sodium Cacodylate, 14.4% (w/v) PEG 8000, 20% (v/v) Glycerol, 1 mM glutamate
分辨率 2.91 Å R-free 0.267
6FQJ GluA2(flop) G724C ligand binding core dimer bound to ZK200775 at 2.50 Angstrom resolution 提交 2018-02-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 H 413–527(115 aa)
链 H 653–797(145 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;287 K;0.2M Ammonium Chloride, 20% PEG 3350, 10microM ZK200775.
分辨率 2.50 Å R-free 0.265
6FQJ GluA2(flop) G724C ligand binding core dimer bound to ZK200775 at 2.50 Angstrom resolution 提交 2018-02-14 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–797(145 aa)
链 G 413–527(115 aa)
链 G 653–797(145 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;287 K;0.2M Ammonium Chloride, 20% PEG 3350, 10microM ZK200775.
分辨率 2.50 Å R-free 0.265
6FQJ GluA2(flop) G724C ligand binding core dimer bound to ZK200775 at 2.50 Angstrom resolution 提交 2018-02-14 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa)
链 C 653–797(145 aa)
链 E 413–527(115 aa)
链 E 653–797(145 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;287 K;0.2M Ammonium Chloride, 20% PEG 3350, 10microM ZK200775.
分辨率 2.50 Å R-free 0.265
6FQJ GluA2(flop) G724C ligand binding core dimer bound to ZK200775 at 2.50 Angstrom resolution 提交 2018-02-14 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 413–527(115 aa)
链 D 653–797(145 aa)
链 F 413–527(115 aa)
链 F 653–797(145 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;287 K;0.2M Ammonium Chloride, 20% PEG 3350, 10microM ZK200775.
分辨率 2.50 Å R-free 0.265
6FQK GluA2(flop) S729C ligand binding core dimer bound to ZK200775 at 1.98 Angstrom resolution 提交 2018-02-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 400–527(128 aa)
链 A 653–797(145 aa)
链 B 400–527(128 aa)
链 B 653–797(145 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;287 K;0.2M Ammonium Chloride, 20% PEG 3350, 10microM ZK200775.
分辨率 1.98 Å R-free 0.256
6GIV Structure of GluA2-N775S ligand-binding domain (S1S2J) in complex with glutamate and Rubidium Bromide at 1.75 A resolution 提交 2018-05-15 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
突变:N775S,N775S 突变:N775S,N775S GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 2 GOL GLYCEROL × 6 BR BROMIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;18-24.4% PEG4000, 0.2-0.3 M Li2SO4, and 0.1 M cacodylate, pH 6.5
分辨率 1.75 Å R-free 0.190
6GL4 Structure of GluA2o ligand-binding domain (S1S2J) in complex with glutamate and sodium bromide at 1.95 A resolution 提交 2018-05-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 652–797(146 aa)
未记录 GLU GLUTAMIC ACID × 2 BR BROMIDE ION × 6 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;25% PEG4000, 0.2M sodium sulfate, 0.1M sodium acetate pH 5.5
分辨率 1.95 Å R-free 0.199
6GL4 Structure of GluA2o ligand-binding domain (S1S2J) in complex with glutamate and sodium bromide at 1.95 A resolution 提交 2018-05-22 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa)
链 B 652–797(146 aa)
未记录 GLU GLUTAMIC ACID × 2 BR BROMIDE ION × 6 NA SODIUM ION × 4 ACT ACETATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;25% PEG4000, 0.2M sodium sulfate, 0.1M sodium acetate pH 5.5
分辨率 1.95 Å R-free 0.199
6HC9 STRUCTURE OF GLUA2 LIGAND-BINDING DOMAIN (S1S2J-L504Y-N775S) IN COMPLEX WITH GLUTAMATE AND TDPAM02 AT 2.4 A RESOLUTION. 提交 2018-08-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 GOL GLYCEROL × 1 CL CHLORIDE ION × 7 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 8 PEG DI(HYDROXYETHYL)ETHER × 3 PGE TRIETHYLENE GLYCOL × 1 FXW 6,6'-(ETHANE-1,2-DIYL)BIS(4-CYCLOPROPYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE) × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;291 K;20% PEG4000, 0.3 M lithium sulfate, 0.1 M phosphate citrate
分辨率 2.40 Å R-free 0.239
6HCA STRUCTURE OF GLUA2 LIGAND-BINDING DOMAIN (S1S1J) IN COMPLEX WITH POSITIVE ALLOSTERIC MODULATOR TDPAM02 AT 1.8 A RESOLUTION 提交 2018-08-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 SO4 SULFATE ION × 10 GOL GLYCEROL × 7 CL CHLORIDE ION × 6 FXW 6,6'-(ETHANE-1,2-DIYL)BIS(4-CYCLOPROPYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE) × 1 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;291 K;24% PEG4000, 0.3 M lithium sulfate, 0.1 M phosphate citrate
分辨率 1.88 Å R-free 0.207
6HCB STRUCTURE OF GLUA2 LIGAND-BINDING DOMAIN (S1S2J-N775S) IN COMPLEX WITH GLUTAMATE AND TDPAM01 AT 1.9 A RESOLUTION. 提交 2018-08-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 SO4 SULFATE ION × 9 GLU GLUTAMIC ACID × 2 GOL GLYCEROL × 4 CL CHLORIDE ION × 4 PEG DI(HYDROXYETHYL)ETHER × 2 D45 6,6'-(Ethane-1,2-diyl)bis(4-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide) × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;15% PEG4000, 0.1 M ammonium sulphate, 0.1 M phosphate citrate
分辨率 1.90 Å R-free 0.192
6HCC STRUCTURE OF GLUA2 LIGAND-BINDING DOMAIN (S1S2J-N775S) IN COMPLEX WITH GLUTAMATE AND TDPAM02 AT 1.6 A RESOLUTION. 提交 2018-08-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 FXW 6,6'-(ETHANE-1,2-DIYL)BIS(4-CYCLOPROPYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE) × 1 GLU GLUTAMIC ACID × 2 SO4 SULFATE ION × 5 GOL GLYCEROL × 7 PEG DI(HYDROXYETHYL)ETHER × 2 CL CHLORIDE ION × 3 ACT ACETATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;291 K;24% PEG4000, 0.3 M lithium sulfate, 0.1 M phosphate citrate
分辨率 1.62 Å R-free 0.182
6HCH STRUCTURE OF GLUA2 LIGAND-BINDING DOMAIN (S1S2J-L504Y-N775S) IN COMPLEX WITH GLUTAMATE AND TDPAM01 AT 1.6 A RESOLUTION. 提交 2018-08-15 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 GLU GLUTAMIC ACID × 2 ZN ZINC ION × 15 D45 6,6'-(Ethane-1,2-diyl)bis(4-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide) × 1 ACT ACETATE ION × 5 GOL GLYCEROL × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;15% PEG4000, 0.1 M zinc acetate, 0.1 M sodium acetate
分辨率 1.60 Å R-free 0.178
6HCH STRUCTURE OF GLUA2 LIGAND-BINDING DOMAIN (S1S2J-L504Y-N775S) IN COMPLEX WITH GLUTAMATE AND TDPAM01 AT 1.6 A RESOLUTION. 提交 2018-08-15 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa)
链 C 653–797(145 aa)
未记录 GLU GLUTAMIC ACID × 2 ZN ZINC ION × 16 D45 6,6'-(Ethane-1,2-diyl)bis(4-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide) × 2 ACT ACETATE ION × 6 GOL GLYCEROL × 2 CL CHLORIDE ION × 4 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;15% PEG4000, 0.1 M zinc acetate, 0.1 M sodium acetate
分辨率 1.60 Å R-free 0.178
6NJL Architecture and subunit arrangement of native AMPA receptors 提交 2019-01-03 Assembly 1 其他组合 异源复合物;蛋白 × 14 PDB 声明:tetradecameric(14) 与蛋白数一致
链 B 1–883(883 aa)
链 D 1–883(883 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 6.70 Å
6NJM Architecture and subunit arrangement of native AMPA receptors 提交 2019-01-03 Assembly 1 其他组合 异源复合物;蛋白 × 16 PDB 声明:hexadecameric(16) 与蛋白数一致
链 B 1–883(883 aa)
链 D 1–883(883 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 6.50 Å
6NJN Architecture and subunit arrangement of native AMPA receptors 提交 2019-01-03 Assembly 1 其他组合 异源复合物;蛋白 × 15 PDB 声明:pentadecameric(15) 与蛋白数一致
链 B 1–883(883 aa)
链 D 1–883(883 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 6.50 Å
6O9G Open state GluA2 in complex with STZ and blocked by AgTx-636, after micelle signal subtraction 提交 2019-03-13 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 LU7 N~1~-{5-[(3-{[3-(L-arginylamino)propyl]amino}propyl)amino]pentyl}-N~2~-[(2,4-dihydroxyphenyl)acetyl]-L-aspartamide × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.80 Å
6PEQ GluA2 in complex with its auxiliary subunit CNIH3 - map LBD-TMD-C3 - with antagonist ZK200775 -without NTD 提交 2019-06-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–868(868 aa)
链 B 1–868(868 aa)
链 C 1–868(868 aa)
链 D 1–868(868 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 8 PAM PALMITOLEIC ACID × 14 CLR CHOLESTEROL × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.97 Å
6Q54 Structure of GluA2 ligand-binding domain (S1S2J) in complex with the agonist (S)-2-Amino-3-(1-ethyl-4-hydroxy-1H-1,2,3-triazol-5-yl)propanoic acid at 1.4 A resolution 提交 2018-12-07 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 SO4 SULFATE ION × 10 HJ8 (2~{S})-2-azanyl-3-(3-ethyl-5-oxidanyl-1,2,3-triazol-4-yl)propanoic acid × 2 GOL GLYCEROL × 4 PGE TRIETHYLENE GLYCOL × 2 CL CHLORIDE ION × 3 CIT CITRIC ACID × 1 LI LITHIUM ION × 3 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;20% PEG4000, 0.3 M lithium sulfate, 0.1 M phosphate-citrate
分辨率 1.40 Å R-free 0.163
6Q60 Structure of GluA2 ligand-binding domain (S1S2J) in complex with the agonist (S)-2-Amino-3-(2-methyl-5-hydroxy-2H-1,2,3-triazol-4-yl)propanoic acid at 1.55 A resolution 提交 2018-12-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
未记录 HJH (2~{S})-2-azanyl-3-(2-methyl-5-oxidanyl-1,2,3-triazol-4-yl)propanoic acid × 2 SO4 SULFATE ION × 4 GOL GLYCEROL × 12 CL CHLORIDE ION × 3 LI LITHIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;10% PEG4000, 0.1 M lithium sulfate, 0.1 M phosphate-citrate, pH 4.5
分辨率 1.55 Å R-free 0.175
6QKC GluA1/2 In complex with auxiliary subunit gamma-8 提交 2019-01-28 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 E2Q 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 12 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;25 mM TRIS, pH 8, 150 mM NaCl and 0.1 % digitonin (w/v)
cryo-EM玻璃化条件 冷冻剂 ETHANE;3uL on grid, 60 sec incubation and 4sec blotting time
分辨率 4.40 Å
6QKZ Full length GluA1/2-gamma8 complex 提交 2019-01-30 Assembly 1 其他组合 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 22–860(839 aa)
链 D 22–860(839 aa)
未记录 E2Q 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;25 mM TRIS, pH 8, 150 mM NaCl and 0.1 % digitonin (w/v)
cryo-EM玻璃化条件 冷冻剂 ETHANE;3uL on grid, 60 sec incubation and 4sec blotting time
分辨率 6.30 Å
6RUQ Structure of GluA2cryst in complex the antagonist ZK200775 and the negative allosteric modulator GYKI53655 at 4.65 A resolution 提交 2019-05-28 Assembly 1 其他组合 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
突变:N235E, N385D, N392Q, K410A, R586Q, C589A 突变:N235E, N385D, N392Q, K410A, R586Q, C589A 突变:N235E, N385D, N392Q, K410A, R586Q, C589A 突变:N235E, N385D, N392Q, K410A, R586Q, C589A GYK (8R)-5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-2H,7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide × 4 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 X-RAY DIFFRACTION
X-ray结晶条件 MICROBATCH;pH 6;279 K;0.1 M MES, 12 % PEG 20,000
分辨率 4.65 Å R-free 0.291
6U5S NTD of GluA2 in complex with CNIH3 - with antagonist ZK200775 - in pseudo-symmetric global conformation 提交 2019-08-28 Assembly 1 其他组合 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–868(868 aa)
链 B 1–868(868 aa)
链 C 1–868(868 aa)
链 D 1–868(868 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.07 Å
6U6I NTD of GluA2 in complex with CNIH3 - with antagonist ZK200775 - in asymmetric global conformation 提交 2019-08-29 Assembly 1 其他组合 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–868(868 aa)
链 B 1–868(868 aa)
链 C 1–868(868 aa)
链 D 1–868(868 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.12 Å
6UCB GluA2 in complex with its auxiliary subunit CNIH3 - with antagonist ZK200775, LBD, TMD, CNIH3, and lipids 提交 2019-09-15 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–868(868 aa)
链 B 1–868(868 aa)
链 C 1–868(868 aa)
链 D 1–868(868 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 8 PAM PALMITOLEIC ACID × 14 CLR CHOLESTEROL × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.28 Å
6UD4 GluA2 in complex with its auxiliary subunit CNIH3 in AS map II - (LBD-TMD-C3(AS) II)- with antagonist ZK200775, without NTD 提交 2019-09-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–868(868 aa)
链 B 1–868(868 aa)
链 C 1–868(868 aa)
链 D 1–868(868 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 CLR CHOLESTEROL × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.30 Å
6UD8 GluA2 in complex with its auxiliary subunit CNIH3 - with antagonist ZK200775 提交 2019-09-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–868(868 aa)
链 B 1–868(868 aa)
链 C 1–868(868 aa)
链 D 1–868(868 aa)
未记录 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 CLR CHOLESTEROL × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.20 Å
6XSR Crystal structure of GluA2 AMPA receptor in complex with trans-4-butylcyclohexane carboxylic acid (4-BCCA) inhibitor 提交 2020-07-16 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–838(814 aa)
链 B 25–838(814 aa)
链 C 25–838(814 aa)
链 D 25–838(814 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 V8G trans-4-butylcyclohexane-1-carboxylic acid × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;8-11% (w/v) PEG 8,000, 0.2 M magnesium acetate and 0.1 M sodium cacodylate (pH 6.3-6.7) or 11-14% (w/v) PEG 6,000, 0.1 M ammonium phosphate and 0.1 M TRIS (pH 7.9-8.0)
分辨率 4.25 Å R-free 0.296
6YK2 Structure of the AMPA receptor GluA2o ligand-binding domain (S1S2J) in complex with the compound (S)-1-[2'-Amino-2'-carboxyethyl]-5,7-dihydrothieno[3,4-d]pyrimidin- 2,4(1H,3H)-dione at resolution 1.60A 提交 2020-04-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 SO4 SULFATE ION × 6 GOL GLYCEROL × 10 CGW (2~{S})-2-azanyl-3-[2,4-bis(oxidanylidene)-5,7-dihydrothieno[3,4-d]pyrimidin-1-yl]propanoic acid × 2 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;15% PEG4000, 0.3M Lithium Sulfate, 0.1M acetate
分辨率 1.61 Å R-free 0.163
6YK3 Structure of the AMPA receptor GluA2o ligand-binding domain (S1S2J) in complex with the compound ( S) - 1- [2'-Amino-2'-carboxyethyl]-5 ,7- dihydropyrrolo[3,4-d]pyrimidin-2,4(1H,3H)-dione at resolution 1.20A 提交 2020-04-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 GOL GLYCEROL × 8 SO4 SULFATE ION × 8 PVQ (S)-1-[2'-Amino-2'-carboxyethyl]-5,7-dihydropyrrolo[3,4-d]pyrimidin-2,4(1H,3H)-dione × 2 NH4 AMMONIUM ION × 2 CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;20% PEG4000, 0.3M ammonium sulfate, 0.1M acetate
分辨率 1.20 Å R-free 0.140
6YK4 Structure of the AMPA receptor GluA2o ligand-binding domain (S1S2J) in complex with the compound ( S) - 1- [2'-Amino-2'-carboxyethyl]-6-methyl-5 ,7- dihydropyrrolo[3,4-d]pyrimidin-2,4(1H,3H)-dione at resolution 1.00A 提交 2020-04-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 SO4 SULFATE ION × 8 GOL GLYCEROL × 8 LI LITHIUM ION × 2 CG8 (2~{S})-2-azanyl-3-[6-methyl-2,4-bis(oxidanylidene)-5,7-dihydropyrrolo[3,4-d]pyrimidin-1-yl]propanoic acid × 2 CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;15.2% PEG4000, 0.3M lithium sulfate, 0.1M acetate
分辨率 1.00 Å R-free 0.120
6YK5 Structure of the AMPA receptor GluA2o ligand-binding domain (S1S2J) in complex with the compound (S)-1-(2'-Amino-2'-carboxyethyl)-5,7-dihydrofuro[3,4-d]- pyrimidine-2,4(1H,3H)-dione at resolution 1.15A 提交 2020-04-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 GOL GLYCEROL × 8 SO4 SULFATE ION × 12 LI LITHIUM ION × 2 PVK (S)-1-(2'-Amino-2'-carboxyethyl)-5,7-dihydrofuro[3,4-d]-pyrimidine-2,4(1H,3H)-dione × 2 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;279 K;PEG4000, lithium sulfate, acetate
分辨率 1.15 Å R-free 0.130
6YK6 Structure of the AMPA receptor GluA2o ligand-binding domain (S1S2J) in complex with the compound (S)-1-(2'-Amino-2'-carboxyethyl)furo[3,4-d]pyrimidin-2,4-dione at resolution 1.47A 提交 2020-04-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
未记录 SO4 SULFATE ION × 8 GOL GLYCEROL × 6 LI LITHIUM ION × 2 CL CHLORIDE ION × 4 OUB (S)-1-(2'-Amino-2'-carboxyethyl)furo[3,4-d]pyrimidin-2,4-dione × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.5;279 K;24.4% PEG4000, 0.15M lithium sulfate, 0.1M phosphate-citrate
分辨率 1.47 Å R-free 0.172
6ZYU Structure of the GluA2 ligand-binding domain (L483Y-N754S) in complex with glutamate and BPAM549 提交 2020-08-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
突变:L483Y,N754S 突变:L483Y,N754S ZN ZINC ION × 4 CAC CACODYLATE ION × 2 ACT ACETATE ION × 4 GLU GLUTAMIC ACID × 2 QSZ (4~{S})-4-cyclopropyl-7-fluoranyl-3,4-dihydro-2~{H}-thiochromene 1,1-dioxide × 2 QSW (4~{R})-4-cyclopropyl-7-fluoranyl-3,4-dihydro-2~{H}-thiochromene 1,1-dioxide × 2 GOL GLYCEROL × 6 CL CHLORIDE ION × 6 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;299 K;Zinc acetate, polyethylene glycol 4000, cacodylate
分辨率 1.90 Å R-free 0.187
6ZYU Structure of the GluA2 ligand-binding domain (L483Y-N754S) in complex with glutamate and BPAM549 提交 2020-08-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 413–527(115 aa)
链 B 653–797(145 aa)
链 C 413–527(115 aa)
链 C 653–797(145 aa)
突变:L483Y,N754S 突变:L483Y,N754S 突变:L483Y,N754S 突变:L483Y,N754S ZN ZINC ION × 6 ACT ACETATE ION × 3 GLU GLUTAMIC ACID × 2 QSZ (4~{S})-4-cyclopropyl-7-fluoranyl-3,4-dihydro-2~{H}-thiochromene 1,1-dioxide × 2 QSW (4~{R})-4-cyclopropyl-7-fluoranyl-3,4-dihydro-2~{H}-thiochromene 1,1-dioxide × 2 GOL GLYCEROL × 3 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;299 K;Zinc acetate, polyethylene glycol 4000, cacodylate
分辨率 1.90 Å R-free 0.187
7OCA Resting state full-length GluA1/A2 heterotertramer in complex with TARP gamma 8 and CNIH2 提交 2021-04-26 Assembly 1 其他组合 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 E2Q 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6 PC1 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 46 CLR CHOLESTEROL × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
7OCC NTD of resting state GluA1/A2 heterotertramer 提交 2021-04-26 Assembly 1 其他组合 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 1–860(860 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
7OCC NTD of resting state GluA1/A2 heterotertramer 提交 2021-04-26 Assembly 2 其他组合 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 1–860(860 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.40 Å
7OCD Resting state GluA1/A2 heterotetramer in complex with auxiliary subunit TARP gamma 8 (LBD-TMD) 提交 2021-04-26 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 E2Q 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide × 4 PC1 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.50 Å
7OCE Resting state GluA1/A2 AMPA receptor in complex with TARP gamma 8 and CNIH2 (LBD-TMD) 提交 2021-04-26 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 E2Q 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide × 4 PC1 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 46 CLR CHOLESTEROL × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.10 Å
7OCF Active state GluA1/A2 AMPA receptor in complex with TARP gamma 8 and CNIH2 (LBD-TMD) 提交 2021-04-26 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 CYZ CYCLOTHIAZIDE × 4 PC1 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 26 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.60 Å
7QHB Active state of GluA1/2 in complex with TARP gamma 8, L-glutamate and CTZ 提交 2021-12-11 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 PAM PALMITOLEIC ACID × 14 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2 79N (2S)-2,3-dihydroxypropyl (7Z)-hexadec-7-enoate × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;25 mM TRIS 150 mM NaCl 0.02 % GDN 87 uM CTZ 100 mM L-Glu
cryo-EM玻璃化条件 冷冻剂 ETHANE;3-4 second blots
分辨率 3.50 Å
7QHH Desensitized state of GluA1/2 AMPA receptor in complex with TARP-gamma 8 (TMD-LBD) 提交 2021-12-12 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 GLU GLUTAMIC ACID × 4 PAM PALMITOLEIC ACID × 10 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2 79N (2S)-2,3-dihydroxypropyl (7Z)-hexadec-7-enoate × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;25 mM TRIS 150 mM NaCl 0.02 % GDN 87 uM CTZ 100 mM L-Glu
cryo-EM玻璃化条件 冷冻剂 ETHANE;3-4 second blots
分辨率 3.60 Å
7RYY Structure of the complex of LBD-TMD part of AMPA receptor GluA2 with auxiliary subunit TARP gamma-5 bound to agonist glutamate 提交 2021-08-26 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 2 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;25 mM glutamate was added to the purified protein and incubated on ice for 30 min before sample preparation
分辨率 4.40 Å
7RYZ Structure of the complex of LBD-TMD part of AMPA receptor GluA2 with auxiliary subunit GSG1L bound to agonist quisqualate 提交 2021-08-26 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;1mM Quisqualate was added to the purified protein and incubated on ice for 30 min before sample preparation
分辨率 4.15 Å
7RZ4 Structure of the complex of AMPA receptor GluA2 with auxiliary subunit TARP gamma-5 bound to competitive antagonist ZK 200775 提交 2021-08-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 24 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;0.1mM ZK was added to the purified protein and incubated on ice for 30 min before sample preparation
分辨率 3.60 Å
7RZ5 Structure of the complex of LBD-TMD part of AMPA receptor GluA2 with auxiliary subunit TARP gamma-5 bound to competitive antagonist ZK 200775 提交 2021-08-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 24 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;0.1mM ZK was added to the purified protein and incubated on ice for 30 min before sample preparation
分辨率 3.30 Å
7RZ6 Structure of the complex of AMPA receptor GluA2 with auxiliary subunit TARP gamma-5 bound to agonist glutamate 提交 2021-08-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 2 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;25 mM glutamate was added to the purified protein and incubated on ice for 30 min before sample preparation
分辨率 4.40 Å
7RZ7 Structure of the complex of AMPA receptor GluA2 with auxiliary subunit TARP gamma-5 bound to agonist Quisqualate 提交 2021-08-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;1 mM Quisqualate was added to the purified protein and incubated on ice for 30 min before sample preparation
分辨率 4.20 Å
7RZ8 Structure of the complex of LBD-TMD part of AMPA receptor GluA2 with auxiliary subunit TARP gamma-5 bound to agonist quisqualate 提交 2021-08-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 22 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;1 mM Quisqualate was added to the purified protein and incubated on ice for 30 min before sample preparation
分辨率 4.10 Å
7RZ9 Structure of the complex of AMPA receptor GluA2 with auxiliary subunit GSG1L in the apo state 提交 2021-08-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.15 Å
7RZA Structure of the complex of AMPA receptor GluA2 with auxiliary subunit GSG1L bound to agonist quisqualate 提交 2021-08-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;1mM Quisqualate was added to the purified protein and incubated on ice for 30 min before sample preparation
分辨率 4.26 Å
7TNK Complex GNNN of AMPA-subtype iGluR GluA2 in complex with auxiliary subunit gamma2 (Stargazin) at low glutamate concentration (20 uM) in the presence of cyclothiazide (100 uM) 提交 2022-01-21 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 1 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.50 Å
7TNL Complex GNGN1 of AMPA-subtype iGluR GluA2 in complex with auxiliary subunit gamma2 (Stargazin) at low glutamate concentration (20 uM) in the presence of cyclothiazide (100 uM) 提交 2022-01-21 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 2 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.59 Å
7TNM Complex GNGN2 of AMPA-subtype iGluR GluA2 in complex with auxiliary subunit gamma2 (Stargazin) at low glutamate concentration (20 uM) in the presence of cyclothiazide (100 uM) 提交 2022-01-21 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 2 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.74 Å
7TNN Complex GGNN of AMPA-subtype iGluR GluA2 in complex with auxiliary subunit gamma2 (Stargazin) at low glutamate concentration (20 uM) in the presence of cyclothiazide (100 uM) 提交 2022-01-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 2 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.91 Å
7TNO Complex GGGN of AMPA-subtype iGluR GluA2 in complex with auxiliary subunit gamma2 (Stargazin) at low glutamate concentration (20 uM) in the presence of cyclothiazide (100 uM) 提交 2022-01-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 3 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.02 Å
7TNP Complex GGGG of AMPA-subtype iGluR GluA2 in complex with auxiliary subunit gamma2 (Stargazin) at low glutamate concentration (20 uM) in the presence of cyclothiazide (100 uM) 提交 2022-01-21 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.96 Å
8AYL Resting state GluA1/A2 AMPA receptor in complex with TARP gamma 8 and ligand JNJ-61432059 提交 2022-09-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 PLM PALMITIC ACID × 8 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 6 OIJ 5-[2-(4-fluorophenyl)-7-(4-oxidanylpiperidin-1-yl)pyrazolo[1,5-c]pyrimidin-3-yl]-1,3-dihydroindol-2-one × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.20 Å
8AYM Resting state GluA1/A2 AMPA receptor in complex with TARP gamma 8 and ligand JNJ-55511118 提交 2022-09-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 XVD 6-[2-chloro-6-(trifluoromethoxy)phenyl]-1H-benzimidazol-2-ol × 2 PLM PALMITIC ACID × 14 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 6 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.30 Å
8AYN Resting state GluA1/A2 AMPA receptor in complex with TARP gamma 8 and ligand LY3130481 提交 2022-09-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 PLM PALMITIC ACID × 14 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 4 OLR 6-[(1~{S})-1-[1-[5-(2-hydroxyethyloxy)pyridin-2-yl]pyrazol-3-yl]ethyl]-3~{H}-1,3-benzothiazol-2-one × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.80 Å
8AYO Open state GluA1/A2 AMPA receptor in complex with TARP gamma 8 and ligand JNJ-61432059 提交 2022-09-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 B 1–860(860 aa)
链 D 1–860(860 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 PLM PALMITIC ACID × 10 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 2 OIJ 5-[2-(4-fluorophenyl)-7-(4-oxidanylpiperidin-1-yl)pyrazolo[1,5-c]pyrimidin-3-yl]-1,3-dihydroindol-2-one × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.30 Å
8C1R Resting state homomeric GluA2 F231A mutant AMPA receptor in complex with TARP gamma-2 提交 2022-12-21 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 PLM PALMITIC ACID × 7 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 5 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.20 Å
8C1S Transmembrane domain of resting state homomeric GluA2 F231A mutant AMPA receptor in complex with TARP gamma 2 提交 2022-12-21 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 PLM PALMITIC ACID × 6 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.00 Å
8FP4 GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 500mM NaCl, 330uM CTZ, and 100mM glutamate (Open-Na610) 提交 2023-01-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 B 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 C 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 D 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
未记录 CL CHLORIDE ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.40 Å
8FP9 GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100mM glutamate (Open-CaNaMg) 提交 2023-01-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion CA CALCIUM ION × 1 CL CHLORIDE ION × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100 mM) and cyclothiazide (CTZ, 0.33 mM) were added before freezing. The 1 M L-glutamic acid stock solution was adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.44 Å
8FPC Conformation 1 of the ligand binding domain (LBDconf1) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100mM glutamate (Open-CaNaMg) 提交 2023-01-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100 mM) and cyclothiazide (CTZ, 0.33 mM) were added before freezing. The 1 M L-glutamic acid stock solution was adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.78 Å
8FPG GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100uM CNQX (Closed-CaNaMg) 提交 2023-01-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion CL CHLORIDE ION × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 0.1 mM) and cyclothiazide (CTZ, 0.33 mM) were added before freezing.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.32 Å
8FPH Conformation 2 of the ligand binding domain (LBDconf2) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100mM glutamate (Open-CaNaMg) 提交 2023-01-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100 mM) and cyclothiazide (CTZ, 330 uM) were added before freezing. The 1 M L-glutamic acid stock solution was adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.14 Å
8FPK LBD conformation 1 of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100uM CNQX (Closed-CaNaMg) 提交 2023-01-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion Y4Y 6-(aminomethyl)-7-nitro-1,4-dihydroquinoxaline-2,3-dione × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 0.1 mM) and cyclothiazide (CTZ, 0.33 mM) were added before freezing.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.76 Å
8FPL LBD conformation 2 (LBDconf2) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100uM CNQX (Closed-CaNaMg) 提交 2023-01-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion 突变:FLAG epitope tag (DYKDDDDK) insertion Y4Y 6-(aminomethyl)-7-nitro-1,4-dihydroquinoxaline-2,3-dione × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, final conc. 0.1mM) and cyclothiazide (CTZ, final conc. 0.33mM) was added before freezing.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.81 Å
8FPS GluA2 flip Q isoform N619K mutant of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100mM glutamate (Open-CaNaMg/N619K) 提交 2023-01-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 B 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 C 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 D 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
突变:N619K 突变:N619K 突变:N619K 突变:N619K CL CHLORIDE ION × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.38 Å
8FPV LBD conformation 1 (LBDconf1) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 500mM NaCl, 330uM CTZ, and 100mM glutamate (Open-Na610) 提交 2023-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.08 Å
8FPY LBD conformation 2 (LBDconf2) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 500mM NaCl, 330uM CTZ, and 100mM glutamate (Open-Na610) 提交 2023-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.98 Å
8FPZ LBD conformation 3 (LBDconf3) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 500mM NaCl, 330uM CTZ, and 100mM glutamate (Open-Na610) 提交 2023-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.01 Å
8FQ1 GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma2, with 150mM CaCl2, 330uM CTZ, and 100mM L-glutamate (Open-Ca150) 提交 2023-01-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 B 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 C 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 D 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) CA CALCIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 5.59 Å
8FQ2 LBD conformation 1 (LBDconf1) of GluA2 flip Q isoform N619K mutant of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100mM glutamate (Open-CaNaMg/N619K) 提交 2023-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 B 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 C 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 D 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
突变:N619K 突变:N619K 突变:N619K 突变:N619K GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.14 Å
8FQ3 LBD conformation 2 (LBDconf2) of GluA2 flip Q isoform N619K mutant of AMPA receptor in complex with gain-of-function TARP gamma-2, with 10mM CaCl2, 150mM NaCl, 1mM MgCl2, 330uM CTZ, and 100mM glutamate (Open-CaNaMg/N619K) 提交 2023-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 B 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 C 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 D 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
突变:N619K 突变:N619K 突变:N619K 突变:N619K GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.17 Å
8FQ5 GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma2, with 140mM NMDG, 330uM CTZ, and 100mM L-glutamate (Open-Na110) 提交 2023-01-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 CL CHLORIDE ION × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.34 Å
8FQ6 LBD of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma2, with 150mM CaCl2, 330uM CTZ, and 100mM L-glutamate (Open-Ca150) 提交 2023-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 B 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 C 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 D 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.14 Å
8FQ8 LBD conformation 1 (LBDconf1) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma2, with 140mM NMDG, 330uM CTZ, and 100mM L-glutamate (Open-Na110) 提交 2023-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) were added before freezing. The 1 M L-glutamic acid stock solution was adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.11 Å
8FQA LBD conformation 2 (LBDconf2) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma2, with 140mM NMDG, 330uM CTZ, and 100mM L-glutamate (Open-Na110) 提交 2023-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.35 Å
8FQB GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma2, with 10mM CaCl2, 140mM NMDG, 330uM CTZ, and 100mM L-glutamate (Open-Ca10) 提交 2023-01-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 B 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 C 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
链 D 1–883(883 aa) 片段:DYKDDDDK near the C-terminal is a FLAG epitope tag used for purification
未记录 CA CALCIUM ION × 1 CL CHLORIDE ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.36 Å
8FQD LBD conformation 1 (LBDconf1) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma2, with 10mM CaCl2, 140mM NMDG, 330uM CTZ, and 100mM L-glutamate (Open-Ca10) 提交 2023-01-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.01 Å
8FQE LBD conformation 2 (LBDconf2) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma2, with 10mM CaCl2, 140mM NMDG, 330uM CTZ, and 100mM L-glutamate (Open-Ca10) 提交 2023-01-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.14 Å
8FQF GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 150mM NaCl, 330uM CTZ, and 100mM glutamate (Open-Na260) 提交 2023-01-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 CL CHLORIDE ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.29 Å
8FQG LBD conformation 1 (LBDconf1) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 150mM NaCl, 330uM CTZ, and 100mM glutamate (Open-Na260) 提交 2023-01-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.01 Å
8FQH LBD conformation 2 (LBDconf2) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 150mM NaCl, 330uM CTZ, and 100mM glutamate (Open-Na260) 提交 2023-01-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.43 Å
8FR0 LBD conformation 3 (LBDconf3) of GluA2 flip Q isoform of AMPA receptor in complex with gain-of-function TARP gamma-2, with 150mM NaCl, 330uM CTZ, and 100mM glutamate (Open-Na260) 提交 2023-01-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;L-glutamic acid (100mM) and cyclothiazide (CTZ, 0.33mM) was added before freezing. The 1M L-glutamic acid stock solution is adjusted to pH 7.4 using NaOH.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.04 Å
8P3Q Homomeric GluA2 flip R/G-unedited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 3 提交 2023-05-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 PLM PALMITIC ACID × 7 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 5 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.95 Å
8P3S Homomeric GluA2 flip R/G-unedited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 2 提交 2023-05-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 PLM PALMITIC ACID × 7 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 5 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.95 Å
8P3X Homomeric GluA2 flip R/G-edited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 1 提交 2023-05-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:F231A 突变:F231A 突变:F231A 突变:F231A 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.36 Å
8P3Y Homomeric GluA2 flip R/G-edited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 3 提交 2023-05-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:F231A 突变:F231A 突变:F231A 突变:F231A 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.55 Å
8P3Z Homomeric GluA2 flip R/G-edited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 2 提交 2023-05-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
突变:F231A 突变:F231A 突变:F231A 突变:F231A 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.46 Å
8QEZ Crystal structure of the AMPA receptor GluA2-L504Y-N775S ligand binding domain in complex with L-glutamate and positive allosteric modulator BPAM395 at 1.55A resolution 提交 2023-09-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 413–527(115 aa)
链 A 653–797(145 aa)
链 B 413–527(115 aa)
链 B 653–797(145 aa)
突变:L504Y,N775S 突变:L504Y,N775S 突变:L504Y,N775S 突变:L504Y,N775S GLU GLUTAMIC ACID × 2 ZN ZINC ION × 5 ACT ACETATE ION × 7 UF5 6-chloranyl-4-cyclopropyl-2,3-dihydrothieno[3,2-e][1,2,4]thiadiazine 1,1-dioxide × 2 CL CHLORIDE ION × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;15.2% PEG4000, 0.1M Zn Acetate, 0.1M Cacodylate pH 6.5
分辨率 1.55 Å R-free 0.195
8QEZ Crystal structure of the AMPA receptor GluA2-L504Y-N775S ligand binding domain in complex with L-glutamate and positive allosteric modulator BPAM395 at 1.55A resolution 提交 2023-09-01 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 413–527(115 aa)
链 C 653–797(145 aa)
突变:L504Y,N775S 突变:L504Y,N775S GLU GLUTAMIC ACID × 2 ZN ZINC ION × 4 ACT ACETATE ION × 2 UF5 6-chloranyl-4-cyclopropyl-2,3-dihydrothieno[3,2-e][1,2,4]thiadiazine 1,1-dioxide × 2 CL CHLORIDE ION × 2 GOL GLYCEROL × 6 CAC CACODYLATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;279 K;15.2% PEG4000, 0.1M Zn Acetate, 0.1M Cacodylate pH 6.5
分辨率 1.55 Å R-free 0.195
8SS2 Structure of AMPA receptor GluA2 complex with auxiliary subunits TARP gamma-5 and cornichon-2 bound to competitive antagonist ZK and channel blocker spermidine (closed state) 提交 2023-05-08 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 26 CLR CHOLESTEROL × 2 AJP Digitonin × 2 SPD SPERMIDINE × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 3.58 Å
8SS3 Structure of LBD-TMD of AMPA receptor GluA2 in complex with auxiliary subunits TARP gamma-5 and cornichon-2 bound to competitive antagonist ZK and channel blocker spermidine (closed state) 提交 2023-05-08 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 50 CLR CHOLESTEROL × 4 AJP Digitonin × 6 SPD SPERMIDINE × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 3.21 Å
8SS4 Structure of LBD-TMD of AMPA receptor GluA2 in complex with auxiliary subunits TARP gamma-5 and cornichon-2 (apo state) 提交 2023-05-08 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 SPD SPERMIDINE × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 3.30 Å
8SS5 Structure of LBD-TMD of AMPA receptor GluA2 in complex with auxiliary subunit TARP gamma-5 (apo state) 提交 2023-05-08 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 NA SODIUM ION × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 3.56 Å
8SS6 Structure of AMPA receptor GluA2 complex with auxiliary subunits TARP gamma-5 and cornichon-2 bound to competitive antagonist ZK, channel blocker spermidine and antiepileptic drug perampanel (closed state) 提交 2023-05-08 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 6ZP 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile × 4 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 28 CLR CHOLESTEROL × 8 NA SODIUM ION × 1 SPD SPERMIDINE × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 3.01 Å
8SS7 Structure of AMPA receptor GluA2 complex with auxiliary subunits TARP gamma-5 and cornichon-2 bound to competitive antagonist ZK, channel blocker spermidine and antiepileptic drug perampanel (closed state) 提交 2023-05-08 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 6ZP 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile × 4 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 28 CLR CHOLESTEROL × 8 NA SODIUM ION × 1 SPD SPERMIDINE × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 2.76 Å
8SS8 Structure of AMPA receptor GluA2 complex with auxiliary subunit TARP gamma-5 bound to competitive antagonist ZK and antiepileptic drug perampanel (closed state) 提交 2023-05-08 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 6ZP 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile × 4 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 14 NA SODIUM ION × 2 CLR CHOLESTEROL × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 2.81 Å
8SS9 Structure of LBD-TMD of AMPA receptor GluA2 in complex with auxiliary subunit TARP gamma-5 bound to competitive antagonist ZK and antiepileptic drug perampanel (closed state) 提交 2023-05-08 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 6ZP 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile × 4 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 14 CLR CHOLESTEROL × 2 NA SODIUM ION × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 2.72 Å
8SSA Structure of AMPA receptor GluA2 complex with auxiliary subunits TARP gamma-5 and cornichon-2 bound to glutamate and channel blocker spermidine (desensitized state) 提交 2023-05-08 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 12 GLU GLUTAMIC ACID × 4 SPD SPERMIDINE × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 3.88 Å
8SSB Structure of LBD-TMD of AMPA receptor GluA2 in complex with auxiliary subunits TARP gamma-5 and cornichon-2 bound to glutamate and channel blocker spermidine (desensitized state) 提交 2023-05-08 Assembly 1 信息不足 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 28 GLU GLUTAMIC ACID × 4 SPD SPERMIDINE × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE;vitrification carried out in nitrogen atmosphere
分辨率 3.66 Å
8VJ6 GluA2 bound to GYKI-52466 and Glutamate, Inhibited State 1 提交 2024-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–842(818 aa)
链 B 25–842(818 aa)
链 C 25–842(818 aa)
链 D 25–842(818 aa)
未记录 A1AB5 4-[(5S,8R)-8-methyl-6,7,8,9-tetrahydro-2H,5H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl]aniline × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.50 Å
8VJ7 GluA2 bound to GYKI-52466 and Glutamate, Inhibited State 2 提交 2024-01-05 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–842(818 aa)
链 B 25–842(818 aa)
链 C 25–842(818 aa)
链 D 25–842(818 aa)
未记录 GLU GLUTAMIC ACID × 4 A1AB5 4-[(5S,8R)-8-methyl-6,7,8,9-tetrahydro-2H,5H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl]aniline × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.85 Å
9B5Z GluA2 flip Q in complex with TARPgamma2 at pH8, consensus structure of LBD-TMD-TARPgamma2 提交 2024-03-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.71 Å
9B60 GluA2 flip Q in complex with TARPgamma2 at pH8, consensus structure of TMD-TARPgamma2 提交 2024-03-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.57 Å
9B61 GluA2 flip Q in complex with TARPgamma2 at pH5, consensus structure of LBD-TMD-TARPgamma2 提交 2024-03-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl. 4 micro litter of protein in buffer was mixed with 1 micro litter of 50mM citric acid buffer (the 50mM citric acid buffer was prepared by diluting 0.5M citric acid/sodium citrate buffer at pH4.0) immediately before applying the sample to the grid.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.81 Å
9B63 GluA2 flip Q in complex with TARPgamma2 at pH5, consensus structure of TMD-TARPgamma2 提交 2024-03-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl. 4 micro litter of protein in buffer was mixed with 1 micro litter of 50mM citric acid buffer (the 50mM citric acid buffer was prepared by diluting 0.5M citric acid/sodium citrate buffer at pH4.0) immediately before applying the sample to the grid.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 2.76 Å
9B64 GluA2 flip Q in complex with TARPgamma2 at pH5, class23, structure of LBD-TMD-TARPgamma2 提交 2024-03-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl. 4 micro litter of protein in buffer was mixed with 1 micro litter of 50mM citric acid buffer (the 50mM citric acid buffer was prepared by diluting 0.5M citric acid/sodium citrate buffer at pH4.0) immediately before applying the sample to the grid.
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.56 Å
9B67 GluA2 flip Q in complex with TARPgamma2 at pH8, class1, structure of LBD-TMD-TARPgamma2 提交 2024-03-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.39 Å
9B68 GluA2 flip Q in complex with TARPgamma2 at pH8, class1, structure of NTD 提交 2024-03-23 Assembly 1 其他组合 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.60 Å
9B69 GluA2 flip Q in complex with TARPgamma2 at pH8, class12, structure of NTD 提交 2024-03-23 Assembly 1 其他组合 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.69 Å
9B6A GluA2 flip Q in complex with TARPgamma2 at pH8, class12, structure of LBD-TMD-TARPgamma2 提交 2024-03-23 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 1–883(883 aa)
链 B 1–883(883 aa)
链 C 1–883(883 aa)
链 D 1–883(883 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;Tris adjusted to pH 8 using HCl
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.35 Å
9DHP Resting state 1 of the GluA2-gamma2 complex 提交 2024-09-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.18 Å
9DHQ Resting state 2 of the GluA2-gamma2 complex 提交 2024-09-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 未记录非水小分子 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.78 Å
9DHR Glutamate activated state of the GluA2-gamma2 complex 提交 2024-09-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.54 Å
9DHS Desensitized state 1 of the GluA2-gamma2 complex 提交 2024-09-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.48 Å
9DHT Desensitized state 2 of the GluA2-gamma2 complex 提交 2024-09-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.31 Å
9E4Y GluA2-gamma2 complex bound to memantine, glutamate, and cyclothiazide 提交 2024-10-25 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 25–841(817 aa)
链 B 25–841(817 aa)
链 C 25–841(817 aa)
链 D 25–841(817 aa)
未记录 377 Memantine × 1 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.30 Å
9E4Z GluA2-gamma2 complex bound glutamate and cyclothiazide 提交 2024-10-25 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 25–841(817 aa)
链 B 25–841(817 aa)
链 C 25–841(817 aa)
链 D 25–841(817 aa)
未记录 GLU GLUTAMIC ACID × 4 CYZ CYCLOTHIAZIDE × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.70 Å
9E9D Structure of full length AMPA receptor GluA2 and auxiliary subunit TARP gamma-2 in complex with anti-miR 17 oligonucleotide RGLS4326 提交 2024-11-08 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
未记录 A1BX3 O-{[(1S,3S,4R,6S,7R)-7-{[(R)-{[(1R,3R,4R,6S,7R)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy}(sulfanyl)phosphoryl]oxy}-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methyl} O-[(2R,3S,4R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxy-2-methyloxolan-3-yl] hydrogen (R)-phosphorothioate × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.24 Å
9E9E Structure of AMPA receptor GluA2 and auxiliary subunit TARP gamma-2 (LBD-TMD) in complex with anti-miR 17 oligonucleotide RGLS4326 提交 2024-11-08 Assembly 1 信息不足 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 25–847(823 aa)
链 B 25–847(823 aa)
链 C 25–847(823 aa)
链 D 25–847(823 aa)
突变:N48D 突变:N48D 突变:N48D 突变:N48D A1BX3 O-{[(1S,3S,4R,6S,7R)-7-{[(R)-{[(1R,3R,4R,6S,7R)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy}(sulfanyl)phosphoryl]oxy}-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methyl} O-[(2R,3S,4R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxy-2-methyloxolan-3-yl] hydrogen (R)-phosphorothioate × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.24 Å
9MRK Glutamate activated state of the GluA2-gamma2 complex prepared at 37 degrees C 提交 2025-01-08 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.62 Å
9MRL Desensitized state 1 of the GluA2-gamma2 complex prepared at 37 degrees C 提交 2025-01-08 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.17 Å
9MRM Desensitized state 2 of the GluA2-gamma2 complex prepared at 37 degrees C 提交 2025-01-08 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.52 Å
9MRN Consensus glutamate activated state of the GluA2-gamma2 complex 提交 2025-01-08 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 A 412–841(430 aa)
链 B 412–841(430 aa)
链 C 412–841(430 aa)
链 D 412–841(430 aa)
未记录 GLU GLUTAMIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.46 Å
9OVT Heteromeric GluA1/A2 in the inactive state, composite map of LBD-TMD 提交 2025-05-31 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 B 413–841(429 aa)
链 D 413–841(429 aa)
未记录 ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4 NA SODIUM ION × 3 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;150 mM NaCl, 20 mM Tris-HCl pH 8.0, and 0.05% digitonin, 100 uM ZK-200775
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.43 Å
9OVU Composite map of GluA1/A2 in the activated state, in complex with positive allosteric modulator (R,R)-2b and agonist glutamate (ATD-LBD-TMD) 提交 2025-05-31 Assembly 1 其他组合 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 B 1–847(847 aa)
链 D 1–847(847 aa)
未记录 GLU GLUTAMIC ACID × 4 NA SODIUM ION × 1 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;150 mM NaCl, 20 mM Tris-HCl pH 8.0, and 0.05% digitonin, 500 uM (R,R)-2b, 1 mM glutamate
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.20 Å
9OVV Heteromeric GluA1/A2-CNIH1 in the activated state, composite map of LBD-TMD 提交 2025-05-31 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 8 PDB 声明:octameric(8) 与蛋白数一致
链 B 413–840(428 aa)
链 D 413–840(428 aa)
未记录 GLU GLUTAMIC ACID × 4 POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 16 FWF N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dipropane-2-sulfonamide × 2 NA SODIUM ION × 1 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;150 mM NaCl, 20 mM Tris-HCl pH 8.0, and 0.05% digitonin, 500 uM (R,R)-2b, 1 mM glutamate
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 3.76 Å
9OVW Heteromeric GluA1/A2 in the desensitized state, composite map of ATD-LBD-TMD 提交 2025-05-31 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 B 25–841(817 aa)
链 D 25–841(817 aa)
未记录 QUS (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID × 4 ELECTRON MICROSCOPY
cryo-EM缓冲液 pH 8;150 mM NaCl, 20 mM Tris-HCl pH 8.0, and 0.05% digitonin, 1 mM quiqualate
cryo-EM玻璃化条件 冷冻剂 ETHANE
分辨率 4.91 Å